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The formation of the myelin sheath is a crucial step during development 
because it enables fast and efficient propagation of signals within the limited 
space of the mammalian central nervous system.  During the process of 
myelination, oligodendrocytes actively interact with the extracellular matrix 
(ECM).  These interactions are considered crucial for proper and timely 
completion of the myelin sheath.  However, the exact regulatory circuits involved 
in the signaling events that occur between the ECM and oligodendrocytes are 
currently not fully understood. Therefore, in this dissertation we investigated the 
role of a known integrator of cell-ECM signaling, namely, focal adhesion kinase 
(FAK), during oligodendrocyte morphological maturation in vivo and in vitro.   
Conditional and inducible FAK-knockout mice (Fakflox/flox: PLP/CreERT 
mice) were generated to observe the effect of FAK loss on myelination in vivo. 
The role of FAK during post-migratory premyelinating oligodendrocyte 
morphological maturation was explored in vitro using primary rat oligodendrocyte 
   ix
 
cultures in combination with siRNA or inhibitor treatment.   
When inducing FAK knockout just prior to and during active myelination in 
vivo, we observed a significant reduction in the number of myelinated fibers 
following initial myelination.  In addition, our data revealed a decreased number 
of primary processes extending from oligodendrocyte cell bodies at this stage of 
development under induction of FAK knockout. In contrast, myelination appeared 
normal on postnatal day 28.   
Our in vitro data demonstrated that reduction of FAK expression or activity 
affected the oligodendrocyte process network maturation in a way that is unique 
to the ECM substrate present.  More specifically, our data suggest that FAK 
restrains the expansion of the oligodendrocyte process network in the presence 
of fibronectin and promotes expansion of the oligodendrocyte process network in 
the presence of laminin-2.  We showed that the FAK-mediated restriction of 
oligodendrocyte morphological maturation is tightly developmentally regulated; 
being highly active during early stages of post-migratory premyelinating 
oligodendrocyte morphological maturation but greatly diminished at the later 
stages of oligodendrocyte development.  Thus, our data suggest that FAK 
controls the efficiency and timing of CNS myelination during its initial stages, at 
least in part, by regulating oligodendrocyte process network morphological 
maturation. 
 
 
 
 
  
Chapter 1 
An introduction to oligodendrocyte biology and focal adhesion kinase 
 
The oligodendrocyte is the myelin producing cell of the central nervous 
system (CNS), responsible for proper conduction of axonal signals.  In certain 
diseases these cells and the myelin that they produce is targeted leading to a 
wide range of dysfunctions.  Although there are oligodendrocyte progenitor cells 
(OPCs) found within areas of myelin damage there is limited, if any, 
remyelination (Nait-Oumesmar et al. 1999, Chang et al. 2002).  The process of 
initial myelination during normal CNS development is not well understood; 
therefore identifying potential key regulators of normal CNS myelination could 
lead to promising therapeutic targets in disease states.  The following 
dissertation research focuses on elucidating the role of focal adhesion kinase 
(FAK), a known integrator of cell-ECM signaling and regulator of cytoskeletal 
remodeling, during oligodendrocyte morphological maturation and myelination.   
 
Why we need myelin 
 The primary function of an oligodendrocyte in the CNS is to produce a 
uniquely lipid-rich myelin sheath that enwraps the axon.  Myelin is one of two 
evolutionary mechanisms utilized in the nervous system to expedite axonal signal 
transduction over great distances.  The first of these mechanisms is the 
enhancement of axonal diameter in proportion to the distance signals travel, 
however, if this were the only mechanism utilized the human spinal cord would 
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be the width of a tree trunk to accommodate the diameter of all the axons 
traveling to our extremities.  The second evolutionary mechanism is the addition 
of the myelin sheath to invest the axons at specific intervals, allowing the speed 
of conduction to increase exponentially without a concomitant increase in the 
diameter of the axon (Sanders & Whitteridge 1946).  In saltatory conduction 
myelin functions to drastically increase the resistance to outward current flow, 
limiting the area of ion exchange to small unmyelinated sections throughout the 
length of the axon, drastically reducing the energy required to propagate the 
signal (Kettenmann 2005, Lazzarini 2004).  
The myelin sheath functions as it does due to both its high-lipid 
composition and the domains that it forms in association with the axonal surface 
(Uzman & Rumley 1958, Simons & Trajkovic 2006).  The domains formed by the 
myelin sheath are: the node of Ranvier, the internode, the paranode, and the 
juxtaparanode.   
The node of Ranvier is the myelin-free zone of the axonal surface in which 
ion exchange is allowed, producing electrical current.  This area only constitutes 
0.1-0.3% of the total axonal surface and is characterized by high sodium channel 
concentration, allowing for ion exchange and subsequent membrane 
depolarization (Salzer et al. 2008, Rosenbluth 2009).  The formation of the node 
is well characterized in the peripheral nervous system, however remains largely 
unclear in the CNS.  Clustering of the sodium channels on the axonal surface in 
the CNS does, however, appear to be regulated by contact with mature 
oligodendrocytes (Kaplan et al. 1997, Kaplan et al. 2001, Dupree et al. 2005). 
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The large area in which the myelin membrane is in direct apposition to the 
axonal surface is the internode (Salzer et al. 2008).  The wraps of myelin at the 
internode compact with myelin maturation; squeezing the cytoplasm from 
between the cellular membranes forming distinct regions, an electron dense 
major dense line and a space between the two extracellular-facing myelin 
membranes called the intraperiod line (De Robertis et al. 1958, Kettenmann 
2005).  The axon diameter regulates whether it requires myelination (Camara et 
al. 2009, Matthews & Duncan 1971).  The number of myelin wraps of the 
internode around the axon is also determined by the diameter of the axon being 
myelinated (Hildebrand & Waxman 1984, Fraher et al.1988, Schwab & Schnell 
1989)  
The areas adjacent to the node of Ranvier were once thought to be one 
structure called the paranode, however, two domains with very different 
molecular characteristics have now been identified: the paranode and the 
juxtaparanode (Kettenmann 2005).  The paranode is the region in which the 
lamella of the myelin sheath terminate on the axonal surface in cytoplasmic-filled 
arms called paranodal loops.  The paranodal loops are uniquely associated with 
the axonal surface through association of axonal contactin with myelin 
membrane surface neurofasin 155 forming paranode specific adhesions called 
transverse bands, which are stabilized by spectrins (Salzer et al. 2008, Simons & 
Trajkovic 2006).   
The second domain, the juxtaparanode, is more proximal to the internode 
than the paranode.  The axonal surface of the juxtaparanode expresses 
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potassium channels as well as unique adhesion molecules that associate with 
the myelin membrane (Salzer et al. 2008).  The function of the potassium 
channels within this region is still poorly understood, however, it is hypothesized 
that the placement of the potassium channels underneath the myelin sheath 
reduces the amount of energy required to repolarize the neuronal membrane 
following an action potential and prevents after potentials (Rosenbluth 2009). 
Active myelination occurs in four distinct phases 1) axonal recognition, 2) 
synthesis of myelin components, 3) axonal wrapping, and 4) myelin compaction 
(Simons & Trajkovic 2006).  While the domains of myelin in the CNS are well 
characterized the process of myelin formation by the oligodendrocyte is still 
largely unknown.  Studies have implicated axonal electrical capability and signals 
sent from the axonal surface in enhancing the initiation of oligodendrocyte 
myelination, however, these mechanisms are still poorly understood (Ishibashi et 
al. 2006, Spiegel & Peles 2006, Simons & Trajkovic 2006).   
 
Multiple Sclerosis (the reason for the research)  
The requirement of the myelin sheath for normal nervous system function 
is evident in diseases in which myelin is disrupted.  There are two main types of 
myelin injury, those that disrupt myelin as a result of another insult (secondary 
myelin diseases) and those injuries that directly affect myelin and 
oligodendrocytes in the CNS (primary myelin diseases) (Kettenmann 2005, 
Lazzarini 2004).  The primary myelin disorders are further subdivided into those 
that disrupt the proper formation of the myelin sheath (dysmyelinating diseases), 
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such as in the case of leukodystrophies, and diseases which destroy properly 
formed myelin (demyelinating diseases) (Lazzarini 2004).   
Multiple sclerosis (MS), the major primary demyelinating disease of the 
CNS, affects approximately 400,000 people in the United States, with 
approximately 200 new cases daily (Multiple Sclerosis Society 2010).  The cause 
of MS remains largely unknown; however, various environmental and genetic 
factors have been linked to increased prevalence.  MS is usually diagnosed in 
young adults between the ages of 20 to 50 years old and is more common in 
females; being more than twice as prevalent as in males (Multiple Sclerosis 
Society 2010).  The signs and symptoms of MS vary widely based on the stage 
of the disease and the area of the CNS most affected.  
There are four main types of MS: preclinical, relapsing-remitting, 
secondary progressive and primary progressive (Fox et al. 2006b).  The 
preclinical stage is characterized as the time prior to onset of symptoms.  The 
majority (85%) of patients diagnosed with MS are in the relapsing-remitting stage 
of the disease, which is characterized by relapsing symptoms that resolve over 
time.  Of people diagnosed with relapsing-remitting MS half will develop the 
secondary-progressive stage of the disease within ten years; in which remissions 
become infrequent and neurological symptoms progressively worsen (Multiple 
Sclerosis Society 2010).  Approximately 15% of MS patients initially present with 
a form of MS in which there are no remissions and the neurological symptoms 
continuously worsen: primary progressive MS (Fox et al. 2006b). 
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There are three main issues to address in MS: the auto-immunological 
aspect, the loss of myelin and oligodendrocytes, and the axonal damage.  
Current therapeutic strategies to combat MS are focused on modulating the 
immune system (Fox et al. 2006b), which has been well characterized in MS.  
Neuronal damage could be precipitated by the immune response or following the 
loss of myelin and oligodendrocyte support, however this is still a point of debate 
within the field (McFarland & Martin 2007, Halfpenny et al. 2002, Geurts & 
Barkhof 2008, Collin et al. 2007).  There are also changes in extracellular matrix 
(ECM) composition within MS lesions which could be associated with the 
pathological symptoms (Sobel & Mitchell 1989, Comabella & Martin 2007, Satoh 
et al. 2009, Cossins et al. 1997, Sobel 1998, van Horssen et al. 2007).   
While the immune response is well characterized in MS there is still much 
that is not well understood regarding oligodendrocyte myelination and there are 
currently no therapies to enhance remyelination.  Premyelinating 
oligodendrocytes are found in the MS lesion, however, they do not properly 
develop and there is limited remyelination (Chang et al. 2002, Kuhlmann et al. 
2008).  Due to the inherent limited capacity for remyelination within MS lesions 
and the lack of knowledge regarding molecular players required for initial myelin 
formation, the examination of molecules, such as focal adhesion kinase (FAK), 
known to regulate morphological remodeling in various cell types could bring us 
one step closer to enhancing remyelination in multiple sclerosis lesions.   
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Oligodendrocyte development 
To elucidate potential factors that would promote remyelination in disease 
states we first need to better understand the normal developmental progression 
of oligodendrocyte differentiation and myelination.  Oligodendrocytes in 
dissociated cell culture develop remarkably similar to in vivo conditions where in 
it has been easier to study their biochemical properties during development 
(Abney et al. 1981, Miller 1996).   
The specification of oligodendrocytes throughout the CNS most likely 
occurs in waves throughout the later aspect of the third trimester in humans or 
early postnataly in the rodent (Kessaris et al. 2006).  Specification of 
oligodendrocytes has been most well characterized in caudal regions of the CNS, 
namely the spinal cord, and is understood to occur similarly within the various 
regions of the CNS.  Oligodendrocytes begin as a constituent of the 
neuroepithelium in the ventral neural tube under the induction of sonic hedgehog 
(Shh) (de Castro & Bribian 2005, Nery et al. 2001, Wegner 2008).   A small 
percentage of oligodendrocytes also arise from the dorsal aspect of the neural 
tube, however the signaling involved in their specification is not well understood, 
accordingly in this section we will focus on the ventrally derived oligodendrocytes 
(Miller 2002, Richardson et al. 2006).  Shh induces the production of the basic 
helix-loop-helix transcription factors olig1 and olig2 (Nery et al. 2001, Nicolay et 
al. 2007).   
Motor neurons expressing olig2 also arise from roughly the same area of 
the neural tube prior to glial specification under the control of shh leading to 
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some debate as to what constitutes an early glial progenitor (Jakovcevski & 
Zecevic 2005, Miller 2002, Masahira et al. 2006, Nicolay et al. 2007, Wegner 
2008).     
In OPCs the transcription factor olig2 is thought to induce the expression 
of the transcription factor sox10 as well as the platelet-derived growth factor α 
receptor (PDGFαR) (Figure 1.1 A) (Wegner 2008, Zhou et al. 2000).  Olig2 also 
plays a role in the expression of Nkx2.2, which has been surrounded by some 
controversy due to the differences in timing of Nkx2.2 expression.  The 
expression of olig2 in association with sox10 and Nkx2.2 has been shown to be 
required for oligodendrocyte fate specification in both the chick and mouse (Liu et 
al. 2007). 
OPCs have a specific membrane constituent including the A2B5 antigen 
and PDGFαR, the ligand for which is expressed by both astrocytes and neurons 
and functions to promote OPC proliferation (Miller 1996, Schnitzer & Schachner 
1982, Timsit et al. 1995, Sim et al. 2006, Simons & Trajkovic 2006).  These 
progenitors migrate vast distances from their periventricular origin to their site of 
action.  Once OPCs reach their final destinations their migratory capabilities drop 
drastically and they differentiate into O4 antigen expressing post-migratory 
oligodendrocytes, which also transiently express the A2B5 antigen early during 
the transition from an OPC (Figure 1.1 B) (Sommer & Schachner 1981, Miller 
1996).  Post-migratory O4+ oligodendrocytes are morphologically distinct from 
OPCs in that O4+ oligodendrocytes have multiple processes, as opposed to the 
more simple bipolar morphology of OPCs.  O4+ post-migratory oligodendrocytes 
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send out a multitude of processes in search of their axonal targets regulated, in 
part, by extracellular cues (Fox et al. 2006a). 
The O4+ post-migratory oligodendrocytes keep their proliferative abilities 
until they further differentiate into O1+ immature oligodendrocytes, which lack the 
ability to proliferate but continue to mature morphologically (Figure 1.1 C) (Miller 
1996).  During development there is an overproduction of OPCs which are 
pruned during this developmental stage based on the number and area of axons 
available to be myelinated (Barres et al. 1992, Miller 2002).  
With the expression of the appropriate transcription factors, O1+ 
oligodendrocytes further differentiate into myelinating oligodendrocytes, which 
express myelin basic protein (MBP) and proteolipid protein (PLP) (Figure 1.1 D) 
(Miller 1996, Sim et al. 2006).  The myelinating oligodendrocytes will again 
remodel their process morphology extensively, producing myelin membrane to 
wrap axonal segments (Bauer et al. 2009, Kettenmann 2005).   
 
Cytoskeletal rearrangement during oligodendrocyte development 
The oligodendrocyte cytoskeleton is composed of mictrotubules and actin 
microfilaments.  The microtubular network is formed by α and β subunits that 
dimerize and associate to form the characteristic cylindrical shape of a 
microtubule and these individual microtubules associate to form a complex 
mictrotubule cytoskeleton.  The formation of microfilaments requires nucleation of 
globular actin monomers into filamentous actin polymers which then associate to 
form a comprehensive microfilament cytoskeleton.  In general, process formation 
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and extension occurs first by filopodia formation followed by widening of the 
narrow fillopodial actin bundles to form lamellipodia and finally, the microfilament 
structure is stabilized by invasion of polymerizing microtubules.   
As discussed above, during development oligodendrocytes undergo vast 
morphological remodeling to transition from an OPC, with a limited process 
network, to a highly complex immature oligodendrocyte, and finally to a fully 
developed myelinating oligodendrocyte.  These morphological transformations 
are largely regulated by the cytoskeleton and molecules that mediate cytoskeletal 
remodeling.   
Tubulin destabilizing factors have been implicated in process formation 
and outgrowth during the extensive morphological changes of the 
oligodendrocyte process network throughout development (Bauer et al. 2009, 
Southwood et al. 2007, Richter-Landsberg 2008).  While the microtubule 
cytoskeleton has been shown to be involved in oligodendrocyte process 
formation, the actin cytoskeleton has been shown to be of great significance for 
initial cytoskeletal remodeling leading to oligodendrocyte process morphological 
remodeling (Song et al. 2001).   
The most studied molecules involved in directly regulating the actin 
cytoskeleton in oligodendrocytes are the Rho family GTPases RhoA, Cdc42 and 
Rac1 (Bacon et al. 2007, Czopka et al. 2009).  These molecules are found 
particularly associated with branch points and the tips of oligodendrocyte 
processes, areas in which actin is also enriched (Song et al. 2001).  
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Signals, such as netrin-1, regulate the actin cytoskeleton in opposing ways 
depending on the stage of oligodendrocyte development.  Early during 
development netrin-1 signaling prevents OPC differentiation and process 
extension through activation of RhoA, which promotes process retraction 
(Rajasekharan et al. 2010).  Later in oligodendrocyte differentiation, however, the 
same netrin-1 signal leads to reduced RhoA activation which allows for 
oligodendrocyte process branching and expansion of the process network 
(Rajasekharan et al. 2010).  The mechanism involved in the switch of GTPase 
regulation associated with signals such as netrin-1 is currently not known.   
The Src family kinases (SFK) member, Fyn, also promotes 
oligodendrocyte process extension and differentiation during later stages of 
development via inactivation of RhoA (Wolf et al. 2001).  RhoA activity has, 
however, been linked to enhanced membrane sheet formation in MBP+ mature 
oligodendrocytes in vitro without affecting the differentiation program of the 
oligodendrocytes (Czopka et al. 2009).  These findings suggest a highly complex 
role for RhoA-mediated cytoskeletal remodeling during oligodendrocyte 
development.  
Unlike RhoA, the GTPases Rac and Cdc42 have been shown to be 
involved in promoting oligodendrocyte process extension and enhancing 
differentiation in vitro (Liang et al. 2004, Hall 1998).  While there is no apparent 
effect on oligodendrocyte development upon Cdc42 or Rac knockout in vivo, 
there is an increase in the amount of myelin out-foldings and a reduction in 
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myelin thickness, which points to a role for cytoskeletal modification in 
appropriate myelin formation (Thurnherr et al. 2006).   
Oligodendrocyte process extension in vitro and initiation of myelination in 
vivo have been shown to involve signaling from neural-Wiskott Aldrich Syndrome 
protein (N-WASP) which activates the actin related protein 2/3 (Arp2/3) complex 
(Bacon et al. 2007).  The Arp2/3 complex functions to promote actin nucleation 
and could play a role in lamellipodia formation during oligodendrocyte process 
remodeling and initial myelination (Bauer et al. 2009).   
As described above, molecular interactions which regulate the actin 
cytoskeleton are crucial for proper and timely myelination.  The precise 
regulatory mechanisms of these complex interactions are still largely unknown; 
however, focal adhesions, and particularly FAK, have been highly implicated in 
cell-ECM signaling regulating cytoskeletal rearrangement.    
 
Focal adhesions: what they are and how they work 
Throughout development changes of the ECM environment induce cellular 
responses.  There are various ways that cells can sense and relate to the 
environment; however via focal adhesion is the most common.  Focal adhesions 
are intracellular multi-molecular complexes of about 1-10 μm2 in size that 
associate with cell membrane receptors and allow ECM interaction with the cell’s 
cytoskeleton (Badley et al. 1980).   
 In any given focal adhesion there are certain required constituents for 
proper function.  Every adhesion site requires a link to the ECM, usually in the 
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form of an integrin receptor.  Integrin receptors also serve as scaffolding proteins 
that associate with various signaling molecules during focal adhesion formation 
and turnover (Schwartz & Ingber 1994, Giancotti & Ruoslahti 1999, Playford & 
Schaller 2004).  Other focal adhesion proteins, such as SFKs, are primarily 
necessary for their catalytic function but also serve to mediate the association of 
interacting molecules within the focal adhesion (Cobb et al. 1994, Cary et al. 
2002, Schwartz & Ingber 1994).  A large molecular complex of this magnitude 
involves so many signaling pathways and therefore requires extensive regulation 
to mediate proper ECM signal transduction.  In this regard FAK has been shown 
to function as a major regulator and integrator of focal adhesion signaling (Mitra 
et al. 2005, Parsons 2003).  
 
Focal adhesion kinase (FAK) 
 FAK is a ubiquitously expressed 125 kDa non-receptor protein tyrosine 
kinase that was characterized by Steve Hanks, Jun-Lin Gaun, and Michael 
Schaller in 1992 (Schaller et al. 1992, Guan & Shalloway 1992, Hanks et al. 
1992).  FAK plays a key role in integrin-mediated focal adhesion signaling.  
During association of integrin receptors with ECM proteins FAK activity is 
enhanced via both autophosphorylation and transphosphorylation by SFKs (Mitra 
et al. 2005, Schlaepfer et al. 1999, Guan & Shalloway 1992, Hanks & Polte 
1997).   
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FAK FERM domain 
 FAK contains an N-terminal FERM (FAK N-terminal ezrin/radixin/moesin 
homology) domain which binds growth factor receptors such as PDGFαR (Mitra 
et al. 2005, Parsons 2003, Schlaepfer et al. 1999).  This domain does not, 
however, appear to play a large role in integrin-stimulated focal adhesion 
dynamics (Mitra et al. 2005).  FAK has a central kinase domain that is located 
just outside of its FERM domain only having ~40% homology to the catalytic 
domains of other protein tyrosine kinases making it a rather unique non-receptor 
tyrosine kinase (Schaller et al. 1992).   
 FAK has many phosphorylation sites, both tyrosine and serine, that 
modulate its activity, however since tyrosine phosphorylation has been more 
closely linked to ECM-mediated adhesion function the serine residues will not be 
discussed (Schlaepfer & Hunter 1996).  FAK is activated by autophosphorylation 
on its Tyr397 site, which is within FAK’s kinase domain, leading to a 
conformational change (Toutant et al. 2002, Zhou et al. 2006).  This allows high-
affinity binding for the Src-homology-2 (SH2) domain of SFKs (Hanks & Polte 
1997).  SFKs are involved in phosphorylating various other tyrosine residues, 
including Tyr861 and Tyr925, allowing for full activation of FAK (Calalb et al. 
1996, Schlaepfer & Hunter 1996).  The Tyr576/577 sites stabilize FAK in an 
active conformation and are two of the sites phosphorylated by SFKs (Cary et al. 
2002, Hanks & Polte 1997).  The kinase domain is also a binding site for the p85 
subunit of phosphotidylinositol 3-kinase (PI3-Kinase) which promotes membrane 
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ruffling and lamellipodia formation (Figure 1.2 red pathway) (Hamadi et al. 2005, 
Clark et al. 1998).   
 
FAK C-terminal domain (FRNK) 
 The FAK C-terminal domain contains two proline rich regions (PRR) that 
bind to Src-homology-3 (SH3) domains of signaling proteins involved in focal 
adhesion formation and turnover, including p130Cas (Figure 1.2 blue pathway), 
which promotes cell migration by activation of Graf (Ras, GTPase regulator 
associated with FAK), and ASAP1 (Arf GTPase-activation protein GAP 1) (Mitra 
et al. 2005).  ASAP1 has a role in regulating cell spreading as well as FAK 
localization to focal adhesions since over expression leads to interruption of both 
conditions (Figure 1.2 green pathway) (Liu et al. 2002).    
 Graf is highly expressed in the brain; however, it is inconclusive if Graf is 
expressed by oligodendrocytes (Taylor et al. 1998).  FAK’s association with Graf 
allows Graf activation through phosphorylation by mitogen-activated protein 
kinase (MAPK) (Taylor et al. 1998).  Active Graf inactivates Rho by up regulating 
the catalysis of Rho bound GTP (active form) to make RhoGDP (inactive form) 
(Figure 1.2 teal pathway) (Taylor et al. 1998).  Graf also inactivates Cdc42, 
however, Rac is not affected by Graf activation which allows Rac to function 
without the antagonistic effects of Rho (Taylor et al. 1998).  Rac allows for 
oligodendrocyte process outgrowth, focal adhesion formation, and morphological 
differentiation and is has been shown to be up regulated during oligodendrocyte 
differentiation (Clark et al. 1998, Liang et al. 2004).   
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FAK FAT domain 
 FAK has a focal adhesion targeting (FAT) domain that is necessary for 
FAK’s localization to focal adhesions (Contestabile et al. 2003, Mitra et al. 2005, 
Schlaepfer et al. 1999).  
The Tyr925 phosphorylation site is located within the FAT domain.  The 
adaptor protein Grb2 binds to phosphorylated Tyr925 linking FAK to the MAPK 
signaling pathway which is involved in the regulation of various cellular functions 
(Figure 1.2 yellow pathway) (Mitra et al. 2005, Schlaepfer et al. 1994, Schlaepfer 
et al. 1999).  Grb2 also binds dynamin on its proline rich domain (PRD), which is 
important for microtubule-induced focal adhesion disassembly, especially in 
migrating cells.  Grb2 probably is the mediator between FAK and dynamin, which 
allows FAK to relate with microtubule dynamics (Ezratty et al. 2005).  In post 
migratory premyelinating oligodendrocytes phosphorylation of the Tyr925 residue 
is reduced compared to migrating OPCs (Fox et al. 2004).   
The integrin-associated proteins talin and paxillin bind FAK on the FAT 
domain (Mitra et al. 2005).  Phosphorylation of paxillin promotes binding of Crk’s 
SH2 domain, increasing Rac activity and stimulating cell motility as well as 
process outgrowth (Figure 1.2 light blue pathway) (Clark et al. 1998).  Paxillin 
also associates with p120RasGAP, which decreases Rho activation through 
activation of p190RhoGAP, leading to enhanced process outgrowth (Brown et al. 
2005).  The FAT domain also binds the Rho-family GTPase p190RhoGEF 
allowing FAK to phosphorylate p190RhoGEF, activating it (Figure 1.2 orange 
pathway).  p190RhoGEF increases the exchange of RhoGDP for RhoGTP 
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activating RhoA which leads to process retraction (Zhai et al. 2003).  FAK 
associates with both GEFS (GTPase activators) as well as GAPs (GTPase 
inactivators) to allow for a cyclical regulation of both Rac, Cdc42 and Rho activity 
by either activating or inactivating GTPases upstream of these molecules (Tomar 
& Schlaepfer 2009).  Via this cyclical regulation of GTPases FAK enables 
processes to remain highly dynamic while encountering the ECM environment.  
 
Life without FAK: FAK null 
 Unfortunately the main phenotype found in constitutive FAK null mice is 
embryonic lethality due to general mesodermal growth defects (Ilic et al. 1995).  
At this stage of development OPCs have not yet been specified therefore 
research on FAK’s role in oligodendrocytes has been largely unknown.  
Fibroblast and endothelial cells collected from FAK null mouse embryos have, 
however, given some helpful clues as to FAK’s role in focal adhesion dynamics 
and cytoskeletal rearrangement.  FAK null fibroblasts still form focal adhesions 
showing that FAK is not necessary for focal adhesion formation in fibroblasts; 
however in neuronal cells FAK plays a role in both adhesion formation and 
turnover (Mitra et al. 2005, Robles & Gomez 2006).  Taken together FAK null 
fibroblasts were found to display reduced focal adhesion turnover, increased 
focal adhesion number and size, decreased motility, proliferation defects, actin 
assembly and location defects, poor cell spreading, and enhanced tyrosine 
phosphorylation throughout the adhesion (Jiang et al. 2006, Webb et al. 2004, Ilic 
et al. 1995).  The FAK null mice have a similar phenotype to those of ECM 
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molecule, fibronectin null animals, demonstrating FAK’s necessity in ECM-
integrin signaling (Ilic et al. 1995, George et al. 1993).  Fibroblasts without FAK 
also have higher than normal Rho activity, due to an inability to regulate Rho 
activity, which could explain the decrease in cell motility and actin defects (Ren et 
al. 2000).  Even the reduction of FAK expression, rather than eliminating it 
altogether, will dramatically reduce the cells ability to function properly (Jiang et 
al. 2006, Hoshina et al. 2007).   
 Since Pyk2 is the only other known member of the focal adhesion kinase 
family it stands to reason that Pyk2 might be compensating for any loss or 
reduction of FAK.  There is an increase in Pyk2 expression in fibroblasts and 
endothelial cells that lack FAK, however, the functions lost along with FAK are 
not entirely regained in the Pyk2 over-expressing cells (Schlaepfer et al. 1999, 
Klingbeil et al. 2001).  While there are additional effects of removing Pyk2 from 
FAKnull cells (Sieg et al. 1998, Lim et al. 2008b) it appears that FAK is the main 
player in focal adhesion dynamics and cytoskeletal remodeling.   
As discussed in the above section FAK is associated with various 
molecular regulators of cytoskeletal remodeling including, but not limited to, Rho, 
Rac, Cdc42 and Ras.  Phosphorylation by FAK is also involved in the localization 
and activation of N-WASP, which leads to actin polymerization and 
oligodendrocyte process extension and initial myelination, as discussed in the 
previous section (Wu et al. 2004).  Due to the high level of involvement for FAK 
in regulating the cytoskeletal remodeling of the oligodendrocyte process network 
during development we explored the effects of removing FAK from 
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oligodendrocytes during a stage of extreme morphological remodeling, i.e. prior 
to myelination.   
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Figure 1.1  Development of an oligodendrocyte from a neuroepithelial cell  to a 
mature oligodendrocyte.  A) oligodendrocyte precursor cells (OPC) which migrate 
to their site of action and further differentiate into B) post-migratory precursor 
oligodendrocytes which begin sending out processes.  C) Immature 
oligodendrocytes undergo drastic morphological maturation ultimately becoming 
myelin-producing D) mature oligodendrocytes.  Markers differentially expressed 
throughout oligodendrocyte development: A2B5, Platelet derived growth factor α 
receptor (PDGFαR), DM20, O4, O1, myelin basic protein (MBP), and proteolipid 
protein (PLP).  Adapted from Pfeiffer et al., 1993. 
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Figure 1.2  Schematic of signaling pathways regulated by FAK via interactions 
with focal adhesion molecules.  FAK promotes cytoskeletal remodeling via 
association of phosphotidylinositol 3-kinase (PI3K) with the kinase domain of 
FAK (red pathway).  The proline rich regions (PRR) of FAK associate with 
p130Cas (blue pathway), GTPase regulator associated with FAK (GRAF; teal 
pathway), and Arf GTPase-activation protein GAP1 (ASAP1; green pathway), 
affecting various cellular functions primarily involved in cytoskeletal 
rearrangement.  Paxillin (light blue pathway), p190RhoGEF (orange pathway), 
and Grb2 (yellow pathway) associate with the focal adhesion targeting (FAT) 
domain of FAK and mediate process dynamics.  Adapted from Schlaepfer et al., 
1999 and Parsons, 2003.  
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Chapter 2 
Focal Adhesion Kinase (FAK): A Regulator of CNS Myelination 
 
(This chapter was accepted as a paper in the Journal of Neuroscience Research 
in February of 2009.  The work reported for this manuscript was preformed with 
vital assistance from Dr. Ray Colello and Dr. Jeff Dupree.) 
 
Introduction 
During development of the central nervous system (CNS), differentiation 
of oligodendrocytes, the myelinating cells, and the process of active myelination 
itself are regulated by complex interactions of the oligodendrocytes' cell surfaces 
with their extracellular environment (Lubetzki-Korn et al. 1983, Fridman et al. 
1985, Notterpek & Rome 1994, Oh & Yong 1996, Buttery et al. 1999, Szuchet et 
al. 2000, Siskova et al. 2006, Colognato et al. 2007). These interactions are 
mediated to a large extent by the integrin class of extracellular matrix (ECM) 
receptors.  (Malek-Hedayat & Rome 1994, Milner & ffrench-Constant 1994, Frost 
et al. 1999, Relvas et al. 2001, Colognato et al. 2002, Colognato et al. 2004, 
Gudz et al. 2002, Baron et al. 2005, Olsen & ffrench-Constant 2005, Benninger 
et al. 2006, Lee et al. 2006). In support of integrin-ECM signaling playing a 
pivotal role in the regulation of oligodendrocyte differentiation and CNS 
myelination, signaling molecules that are effectors in integrin-mediated signaling 
cascades have also been implicated in these processes (Chun et al. 2003, Fox et 
al. 2004, Liang et al. 2004, Hoshina et al. 2007, Sloane & Vartanian 2007). 
 22
  
One of the main regulators of integrin-ECM signaling is focal adhesion 
kinase (FAK). FAK, also known as protein tyrosine kinase 2, is a ubiquitously 
expressed nonreceptor protein tyrosine kinase that can be activated by a number 
of extracellular signals (Hanks et al. 1992, Schaller et al. 1992, Schlaepfer et al. 
1999, Parsons 2003, Mitra et al. 2005, Mitra & Schlaepfer 2006). FAK has been 
found to be expressed in cells of the oligodendrocyte lineage and is present in 
myelin (Kilpatrick et al. 2000, Bacon et al. 2007). Interestingly, phosphorylation of 
FAK at its Tyr397 site, which represents a critical event for its activation and 
biological effects, has been described as occurring primarily in postmigratory 
differentiating oligodendrocytes and not in migratory oligodendrocyte progenitor 
cells (Liang et al. 2004). Furthermore, additional phosphorylation events of FAK 
tyrosine residues regulate its overall function (Schlaepfer & Hunter 1996, Hanks 
& Polte 1997, Cohen & Guan 2005). Phosphorylation of one of these residues, 
namely, the Tyr925 residue, has been found to be significantly altered during the 
initial stages of myelination (Fox et al. 2004). Taken together, these data suggest 
a role for FAK in regulating oligodendrocyte maturation and/or CNS myelination 
itself. However, this role of FAK has not yet been well characterized. 
Ubiquitous FAK knockout is early embryonically lethal because of general 
mesodermal defects (Furuta et al. 1995, Ilic et al. 1995). Therefore, to investigate 
the potential role of FAK in the regulation of oligodendrocyte maturation and/or 
CNS myelination, we generated oligodendrocyte-specific and inducible FAK-
knockout mice using the Cre-loxP system (Fakflox/flox: PLP/CreERT mice). Our 
results revealed that when inducing FAK knockout in these mice just prior to and 
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during the initial stages of myelination of the optic nerve, myelination was 
reduced on postnatal day 14 (P14). In addition, our data showed that the 
induction of FAK knockout resulted in a reduced number of primary 
oligodendrocyte processes at this developmental age. However, this phenotype 
appears to be transient because the number of myelinated fibers on postnatal 
day 28 (P28) was comparable under both control and knockout conditions. Taken 
together, these data demonstrate that FAK is involved in regulating the efficiency 
and timing of myelination in its initial stages and suggest that this regulatory role 
may involve the control of oligodendrocyte process outgrowth and/or remodeling. 
 
Materials and Methods 
 
Animals and Induction of FAK Knockout 
Mice in which the second kinase domain exon of Fak is flanked by loxP 
sites (Fakflox/flox mice) were bred to mice that express, under the control of the 
proteolipid protein (PLP) promoter, Cre recombinase fused to a tamoxifen-
inducible mutated ligand-binding domain of the human estrogen receptor 
(PLP/CreERT mice, kindly provided by B. Popko, University of Chicago; (Beggs 
et al. 2003, Doerflinger et al. 2003). Both strains are on a C57BL/6 genetic 
background. Litters used for the present study were derived from males 
homozygous for the floxed Fak locus and heterozygous for the PLP/CreERT 
locus and females homozygous for the floxed Fak locus but negative for the 
PLP/CreERT locus. Thus, knockout and control mice were derived from the same 
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breeding pairs. To induce FAK knockout, 300-µL intraperitoneal injections of 3 
mg of tamoxifen or vehicle (sunflower oil) were administered daily into lactating 
mothers from postnatal day 2 (P2) through P12, with P0 referring to the day of 
birth (Leone et al. 2003). Animals were analyzed at P14 and P28. To confirm 
successful Cre-mediated recombination under the above-described conditions, 
PLP/CreERT mice were additionally bred to Gt(ROSA)26Sortm1(EYFP)Cos reporter 
mice, which contain an enhanced yellow fluorescent protein (EYFP) gene 
inserted into the Gt(ROSA)26Sor locus and are also on a C57BL/6 genetic 
background (Jackson Laboratory, Bar Harbor, ME; see also (Srinivas et al. 
2001). In these reporter mice, expression of EYFP is blocked by an upstream 
loxP-flanked STOP sequence and only induced on successful Cre-mediated 
recombination at the ROSA26 locus. Gt(ROSA)26Sortm1(EYFP)Cos:PLP/CreERT 
mice were treated as described above and analyzed at P14. All animal studies 
were approved by the Institutional Animal Care and Use Committee at Virginia 
Commonwealth University. 
PCR Analysis 
For genotype analysis, DNA was extracted from tail clips using a DNeasy 
blood and tissue kit (Qiagen, Valencia, CA). For analysis of recombination 
efficiency upon tamoxifen treatment, optic nerves were dissected from P14 
animals, and DNA was extracted as described above. Polymerase chain reaction 
(PCR) was performed using a Taq PCR Core Kit (Qiagen, Valencia, CA) and a 
PTC-200 DNA Engine Cycler (MJ Research, Waltham, MA). The following primer 
pairs were used at the indicated annealing temperatures: CreERT forward (5-
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GATGTAGCCAGCAGCATGTC-3) and CreERT reverse (5-
ACTATATCCGTAACCTGGAT-3) at 50°C and FAK-flox-P1 (5-
GACCTTCAACTTCT CATTTCTCC-3) and FAK-flox-P2 (5-GAATGCTACAG 
GAACCAAATAAC-3) at 55°C. Custom oligonucleotides were obtained from 
MWG-Biotech (Huntsville, AL). The PCR cycling conditions were: 2 min at 94°C, 
followed by 35 cycles of amplification (45 sec at 94°C; 1 min, 30 sec at the 
respective annealing temperature; and 45 sec at 72°C) and 4 min of extension at 
72°C. Amplified DNA was analyzed using agarose gel electrophoresis and the 
VersaDoc 4000 imaging system (Bio-Rad, Hercules, CA). 
 
Immunohistochemistry 
Immunohistochemistry was performed on longitudinal sections of optic 
nerves dissected from tamoxifen-treated P14 
Gt(ROSA)26Sortm1(EYFP)Cos:PLP/CreERT mice. Mice were deeply anesthetized, 
transcardially perfused with 4% paraformaldehyde in 0.1M Millonigs buffer (150 
mM sodium phosphate monobasic/100mM sodium hydroxide) and postfixed for 
24 hr. Optic nerves were removed, cryoprotected in 30% sucrose/PBS, 
embedded in Tissue-Tek on dry ice, and 10-µm sections were then cut on a 
Shandon SME Cryotome (Thermo Scientific, Philadelphia, PA). Sections were 
immunolabeled after a permeabilization step in ice-cold acetone (Dupree et al. 
1999) using the following antibodies: mouse monoclonal anti-APC/CC1 
(EMD/Calbiochem, Gibbstown, NJ), rabbit polyclonal anti-GFP/YFP (Millipore, 
Temecula, CA), and secondary Alexa Fluor 594-conjugated donkey antimouse 
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IgG and Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen/Molecular 
Probes, Carlsbad, CA). Sections were analyzed by confocal microscopy using a 
Leica TCS SP2 AOBS System (Leica Microsystems Inc., Bannockburn, IL). 
 
Light and Electron Microscopic Analysis 
P14 and P28 mice treated with either tamoxifen or sunflower oil were 
deeply anesthetized and transcardially perfused with 4% paraformaldehyde/2.5% 
glutaraldehyde in 0.1M Millonigs buffer (Dupree et al. 1998).  Mice were postfixed 
for 1-2 weeks in aldehyde fixative. Optic nerves were dissected out and 
incubated for 1 hr in 1% osmium tetroxide/0.1M Na-cacodylate buffer (Electron 
Microscopy Sciences, Ft. Washington, PA). Specimens were dehydrated with 
ethanol and embedded in Epon resin (Electron Microscopy Sciences, Ft. 
Washington, PA). 
For light microscopic analysis, semithin (1-µm) transverse sections were 
taken every 1 mm throughout the length of the optic nerve, stained with toluidine 
blue, and imaged using a Nikon ECLIPSE E800M microscope equipped with a 
Spot RT CCD camera (Nikon Inc., Melville, NY). The number of myelinated fibers 
was determined in a blinded fashion for each entire transverse section. The 
average number for the control sections was set to 100%, and each value was 
calculated accordingly. Statistical significance was determined using the 
Student's t test. 
For electron microscopic analysis, ultrathin transverse sections (90 nm) 
were taken 1 mm from the lamina cribrosa and at 1-mm intervals along the length 
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of the optic nerve. Sections were collected on Formvar-coated slotted grids and 
stained with uranyl acetate and lead citrate. Images were taken using a JEOL 
JEM1230 transmission electron microscope equipped with an Ultrascan 4000 
Gatan CCD camera. 
 
Results 
 
Administration of Tamoxifen to Lactating Females Induces Cre-Mediated 
Recombination in the Optic Nerve and in Cells of Oligodendrocyte Lineage 
in Early Postnatal Offspring Containing the PLP/CreERT Locus 
To determine the in vivo role of FAK in differentiating oligodendrocytes 
during the developmental period of myelination, spatially and temporally 
controlled transgenic FAK-knockout mice were generated using an inducible Cre-
loxP system. More specifically, mice in which the second kinase domain exon of 
Fak is flanked by loxP sites (Fakflox/flox mice; Figure 2.1B) were bred to mice that 
express, under the control of the PLP promoter, Cre recombinase fused to a 
tamoxifen-inducible mutated ligand binding domain of the human estrogen 
receptor (PLP/CreERT mice; Figure 2.1B; (Beggs et al. 2003, Doerflinger et al. 
2003)). Because of the breeding strategy used (see Materials and Methods 
section), all mice analyzed for the potential effects of FAK-knockout induction 
were homozygous for the floxed Fak locus and either heterozygous for the 
PLP/CreERT locus (Fakflox/flox:PLP/CreERT mice) or lacking the PLP/CreERT locus 
(Fakflox/flox littermate controls). It has been previously established that only upon 
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administration of tamoxifen is CreERT translocated from the cytoplasm to the 
nucleus, where it is able to catalyze recombination at loxP sites (Leone et al. 
2003). In addition, it has been shown that the PLP promoter used for the 
generation of the PLP/CreERT mice is well suited to direct transgene expression 
to differentiating oligodendrocytes (Wight et al. 1993, Fuss et al. 2000, Fuss et al. 
2001, Doerflinger et al. 2003). Thus, the use of the above-described Fakflox/flox: 
PLP/CreERT mice allowed for design strategies in which to induce Cre-mediated 
recombination and thus FAK knockout specifically in differentiating 
oligodendrocytes and during the developmental period of active myelination. 
Because of the region-specific timing of active myelination in the CNS, however, 
individual knockout, that is, tamoxifen injection, strategies need to be employed 
for specific CNS regions (Caley & Maxwell 1968, Foran & Peterson 1992, Leone 
et al. 2003, Thomson et al. 2005).  
For the study presented here, we chose the optic nerve as the anatomical 
region of interest because of its relatively simple morphology and the well-
described chronology of oligodendrocyte differentiation and myelination (Skoff et 
al. 1976a, Skoff et al. 1976b, Skoff et al. 1980, Tennekoon et al. 1977, 
Hildebrand & Waxman 1984, Hunter & Bedi 1986, Butt & Ransom 1993, Colello 
et al. 1995, Thomson et al. 2005). In the optic nerve of developing C57Bl/6 mice, 
that is, animals of genetic background similar to that of the Fakflox/flox:PLP/CreERT 
mice, both oligodendrocyte differentiation and myelination proceed from the 
retinal to the chiasmatic end of the nerve (Thomson et al. 2005). First axonal 
contact of oligodendrocyte processes can be seen at the retinal end around 
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postnatal day 6 (P6). At this point, oligodendrocytes also begin to express the 
PLP isoform of PLP/DM20 and are thus considered to represent a myelinating 
stage of the lineage (Tennekoon et al. 1977, Trapp et al. 1997, Thomson et al. 
2005). At the chiasmatic end, such initially myelinating cells are first observed at 
P8. Mature, that is, compacted, myelin can be found extended over the whole 
length of the nerve around P15 (Foran & Peterson 1992). Thus, to induce Cre-
mediated recombination in the optic nerve just prior to and during the 
developmental period of active myelination, tamoxifen or sunflower oil as vehicle 
control were administered daily to lactating mothers from 2 to 12 days 
postpartum, and animals were analyzed during the active stages of myelination, 
that is, at P14, and at a mature stage, that is, at P28 (Figure 2.1A). Successful 
Cre-mediated recombination at the Fak locus was assessed by PCR analysis 
(Figure 2.1C). Recombination could be observed as early as P4 (data not 
shown). At this point, oligodendrocytes in the optic nerve for the most part are at 
a progenitor stage, at which they express low levels of FAK (Liang et al. 2004). 
Thus, even in a case of a relatively stable FAK protein, FAK protein levels will be 
reduced upon FAK-knockout induction because it inhibits the normal 
developmental up-regulation of FAK expression. At P14, approximately 40% of 
the cells in the optic nerve are oligodendrocytes (Barres et al. 1992). Thus, the 
recombination efficiency of approximately 40% observed in our studies (Figure 
2.1C) suggests efficient Cre-mediated recombination in cells of the 
oligodendrocyte lineage, at least at this developmental age. In the other cell 
types of the optic nerve, which are primarily astrocytes, the PLP promoter is not 
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operative, and thus recombination cannot be induced upon administration of 
tamoxifen. To further confirm successful Cre-mediated recombination in cells of 
the oligodendrocyte lineage under the conditions depicted in Figure 2.1A, 
PLP/CreERT mice were bred to Gt(ROSA)26Sortm1(EYFP)Cos reporter mice, in 
which expression of EYFP is blocked by an upstream loxP-flanked STOP 
sequence and only induced upon successful Cre-mediated recombination 
(Srinivas et al. 2001). As a marker for cells of the oligodendrocyte lineage, an 
antibody to cytoplasmic APC/CC1 was used (Bhat et al. 1996, Fuss et al. 2000). 
As shown in Figure 2.1D, EYFP expression could easily be detected in 
APC/CC1-positive cells of the optic nerve of a tamoxifen-treated P14 
Gt(ROSA)26Sortm1(EYFP)Cos:PLP/CreERT mouse. Taken together, the above data 
confirm that under the conditions depicted in Figure 2.1A, Cre-mediated 
recombination at loxP sites occurs efficiently in the optic nerve and in cells of the 
oligodendrocyte lineage during early postnatal development (P4-P14) of offspring 
containing the PLP/CreERT locus. 
 
At P14, the Number of Myelinated Axons is Decreased in Optic Nerves of 
Tamoxifen-Treated Fakflox/flox:PLP/CreERT Mice 
To assess the extent to which FAK may regulate developmental 
myelination, we determined the number of myelinated fibers in tamoxifen-treated 
Fakflox/flox: PLP/CreERT and control mice at P14 using light microscopy (Figure 
2.2). To eliminate the possibility that varying levels of myelination along the 
length of the optic nerve affect the outcome of our analysis, we examined 
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sections taken at 1-mm intervals along the whole length of the nerve (Skoff et al. 
1980). At all levels, the number of myelinated fibers was found to be reduced in 
the Fakflox/flox:PLP/CreERT mice compared with their Fakflox/flox litter mates (see 
example in Figure 2.2A). When averaging the number of myelinated fibers for all 
levels, these were found to be significantly decreased, by more than 30%, in 
Fakflox/flox:PLP/CreERT mice compared to Fakflox/flox mice (Figure 2.2B,C). No such 
differences were noted when analyzing vehicle-treated Fakflox/flox: PLP/CreERT 
and Fakflox/flox mice (data not shown).  
To determine the resolution of our type of analysis, we compared semithin 
sections (light microcopy) with consecutive ultrathin sections (electron 
microscopy). As shown in Figure 2.3, such analysis revealed that visualizing 
transverse sections of the optic nerve using light microscopy allowed myelinated 
axons enwrapped with as few as four layers of myelin to be distinguished. Thus, 
our data demonstrate that FAK is involved in the regulation of the initial steps of 
myelination and/or myelin wrapping. 
 
At P14, the Number of Primary Oligodendrocyte Processes is Reduced in 
Optic Nerves of Tamoxifen-Treated Fakflox/flox:PLP/CreERT Mice 
To further investigate the above role of FAK during developmental 
myelination of the optic nerve, we determined the total number of cells in the 
semithin 1-µm transverse sections taken at 1-mm intervals (measured from the 
lamina cribrosa). This analysis revealed no differences between P14 
Fakflox/flox:PLP/CreERT mice and their Fakflox/flox littermates (Figure 2.4A), 
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suggesting that the effect of FAK-knockout induction on myelination may not be a 
result of changes in the number of oligodendrocytes. However, when analyzing 
the number of primary processes, that is, processes that directly extend from 
oligodendrocyte cell bodies, a significant decrease, of approximately 30%, was 
observed in P14 Fakflox/flox: PLP/CreERT optic nerves compared to optic nerves 
from P14 Fakflox/flox littermates (Figure 2.4B-D). Oligodendrocyte cell bodies can 
be easily distinguished from cell bodies of the major other cell type found in the 
optic nerve, namely, astrocytes, as astrocytes exhibit abundant glycogen 
granules and contain intermediate filaments. Thus, we are confident that to a 
large extent, our analysis was restricted to oligodendrocytes. Taken together, the 
above data therefore suggest that the decrease in the number of myelinated 
fibers seen upon induction of FAK knockout is a result, at least in part, of 
impaired oligodendrocyte process outgrowth and/or remodeling.  
At P28, the Number of Myelinated Axons within Optic Nerves is 
Comparable Between Tamoxifen-Treated Fakflox/flox and 
Fakflox/flox:PLP/CreERT Mice 
To assess the extent to which the above-observed effects of FAK-
knockout induction during periods of active myelination are persistent into 
adulthood, we determined the number of myelinated axons at P28. At this age, 
the number of myelinated axons in the optic nerve was found to be comparable 
between Fakflox/flox and Fakflox/flox:PLP/CreERT mice (Figure 2.5). These data 
suggest that the role of FAK may be of particular importance for the efficiency 
and timing of the initial stages of myelination.  
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Discussion  
In the present study, we have demonstrated that induction of FAK 
knockout just prior to and during active stages of myelination results in 
hypomyelination in the optic nerve at a time-point when normally myelinated 
fibers can be found extended throughout the whole length of the nerve, that is, at 
P14. Furthermore, our data suggest that this effect of FAK-knockout induction is 
a result at least in part of reduced outgrowth and/or impaired remodeling of 
primary oligodendrocyte processes. However, myelination appears to have 
reached normal levels by P28. Thus, our data suggest that in vivo in the optic 
nerve, FAK promotes efficient and properly timed myelination during the active 
phases of myelin sheath formation. 
In light of the known role of FAK in integrating ECM-integrin signaling 
events, our data are in support of the previously suggested but somewhat 
controversial regulatory role of integrin signaling during CNS myelination (Relvas 
et al. 2001, Benninger et al. 2006, Lee et al. 2006, Colognato et al. 2007). 
Furthermore, they are in good agreement with findings that demonstrated 
developmental myelination to be controlled by signals up- and downstream of the 
integrin-FAK axis, such as laminin2/ merosin and Fyn, respectively (Biffiger et al. 
2000, Sperber et al. 2001, Chun et al. 2003). Interestingly, expression of 
dominant-negative β1 integrin, laminin2/merosin deficiency, and Fyn knockout all 
result in hypomyelination in a region-specific manner, with only the optic nerve 
affected to a similar extent in these mutant mice. Thus, the roles of ECM 
proteins, integrins, and FAK may differ in different CNS areas. Those areas 
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potentially not controlled by FAK may depend on the FAK-related kinase proline-
rich tyrosine kinase 2 (Pyk2). Although Pyk2 expression in oligodendrocytes has 
not been well defined, it represents a good candidate for functionally substituting 
FAK (Avraham et al. 2000, Klingbeil et al. 2001, Orr & Murphy-Ullrich 2004, 
Nakamura et al. 2007). However, future studies will be necessary to dissect the 
exact roles of FAK and Pyk2 in the regulation of CNS myelination. 
FAK has been characterized as a regulator of morphological remodeling 
and, in particular, has been implicated in the regulation of process outgrowth 
from both neurons and oligodendrocytes (Beggs et al. 2003, Falk et al. 2005, 
Robles & Gomez 2006, Hoshina et al. 2007). Our data demonstrating a reduction 
in the number of primary processes on induction of FAK knockout are consistent 
with these previous findings. A pivotal role of FAK in the regulation of 
morphological oligodendrocyte differentiation is further supported by the fact that 
Fyn, a known FAK effector, has been found to be important for the development 
of the extensive oligodendrocyte process network (Osterhout et al. 1999, Buttery 
& ffrench-Constant, Klein et al. 2002, Liang et al. 2004).  In the case of Fyn, this 
morphological maturation can be regulated independent of changes in gene 
expression typically associated with oligodendrocyte differentiation (Osterhout et 
al. 1999). The extent to which FAK is involved in the control of gene expression 
in differentiating oligodendrocytes, however, has not yet been characterized. 
Nevertheless, the above data support the idea that impaired process outgrowth 
and/or remodeling, at least in part, may be responsible for the hypomyelination 
seen in the optic nerves of tamoxifen-treated Fakflox/flox:PLP/CreERT mice. 
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In our studies, the effect of FAK-knockout induction on myelination was 
found to be transient, with normal levels of myelination detectable at P28. Thus, 
FAK's role appears to mainly affect the efficiency and timing of myelination. 
However, as discussed above, Pyk2 may be able to substitute FAK's function not 
only in a region-specific manner but also in the case of loss of FAK. Future 
studies will be necessary to assess such a potentially important role of Pyk2 in 
myelination. 
Taken together, our data suggest that FAK promotes efficient and properly 
timed myelination in the optic nerve, where it likely acts as an effector of integrin 
signaling activated by oligodendrocyte-ECM interactions. Our data further 
suggest that this signaling event promotes process outgrowth and potentially 
remodeling during the initial stages of myelination. Impairment of these steps of 
oligodendrocyte maturation appears to be responsible for, at least in part, the 
limited repair of the myelin sheath seen in lesions of patients suffering from the 
major demyelinating disease in humans: multiple sclerosis (Chang et al. 2002, 
Franklin & ffrench-Constant 2008, Kuhlmann et al. 2008). Thus, increasing the 
understanding of the role of FAK in CNS myelination not only furthers our 
understanding of normal CNS development but may also reveal novel targets 
suitable to stimulate remyelination under pathological demyelinating conditions. 
 
 
 
 
 
 36
  
 
 
 
 
 
 
 
 
 
Figure 2.1 Induction of Cre-mediated recombination in Fakflox/flox:PLP-CreERT 
and Gt(ROSA)26Sortm1(EYFP)Cos:PLP-CreERT mice. A: Injection paradigm used to 
induce Cre-mediated recombination at the floxed fak or ROSA26 locus just prior 
to and during myelination of the optic nerve. Times of initial myelination defined 
as described by Thomson et al. 2005 (Thomson et al. 2005). B: Schematic at the 
top depicts the transgene construct used to generate the PLP/CreERT mice 
(Doerflinger et al. 2003). The PLP cassette contains 2.4 kb of the 5’-flanking 
DNA, exon 1 and intron 1 of the Plp gene. The cDNA sequence coding for 
CreERT was inserted 3’ of intron 1. For transcription termination, a simian virus 
(SV) 40 poly(A) signal sequence was added. Middle schematic depicts the floxed 
Fak locus, in which the second kinase domain exon of Fak is flanked by loxP 
sites (Beggs et al. 2003). Upon crossbreeding and tamoxifen application, 
recombination at the Fak locus was induced as depicted in the bottom schematic. 
P1 and P2 indicate the location of PCR primers used for genotyping. C: PCR 
analysis of recombination at the Fak locus in optic nerves of tamoxifen-treated 
Fakflox/flox:PLP-CreERT and Fakflox/flox mice at P14. Primers P1 and P2 depicted in 
A were used, and the amount of each amplification product was determined 
using the VersaDoc 4000 imaging system (Bio-Rad, Hercules, CA). Bar graph 
depicts means ± SEM (n = 3 per genotype); *, statistically significant as 
determined by Student's t test. D: Representative confocal images of P14 optic 
nerve sections taken from tamoxifen-treated Gt(ROSA)26Sortm1(EYFP)Cos: PLP-
CreERT mice after double-labeling for APC/CC1 and YFP. Nuclei were stained 
using Hoechst. Images depict single channel representations of a single optical 
section (approximately 0.2-µm x-z resolution). Scale bar = 10 µm 
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Figure 2.1 
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Figure 2.2 Reduced number of myelinated fibers in optic nerves of tamoxifen-
treated Fakflox/flox:PLP/CreERT mice at P14. A: Numbers of myelinated fibers 
within entire transverse sections of P14 optic nerves at approximately 1, 2, and 3 
mm from the lamina cribosa. Mean for all control values was set to 100%, and 
percentages for all data points were calculated accordingly. Results for a 
representative optic nerve littermate pair are shown. B: Numbers of myelinated 
fibers averaged over all three intervals of the optic nerve. Percentages were 
calculated as described in A. Bar graph depicts means ± SEM (n = 3 per 
genotype); *, statistically significant as determined by the Student's t test. C: 
Representative pictures of semithin sections from Fakflox/flox (left) and 
Fakflox/flox:PLPCreERT (right) optic nerves taken at approximately 1, 2, and 3 mm 
from the lamina cribosa. Scale bars = 10 µm. 
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Figure 2.2  
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Figure 2.3 Resolution (visual threshold) for the detection of a myelinated fiber in 
the optic nerve was approximately 4 layers of myelin at the light microscopic 
level. A: Semithin section of the optic nerve imaged at the light microscopic level. 
Scale bar = 10 µm. B, C: Ultrathin sections taken immediately adjacent to the 
semithin section shown in A and imaged at the electron microscopic level. Scale 
bar = 2 µm (B) and 200 nm (C). Rectangle in A marks the area shown in B ( *, 
myelinated fibers that can be identified as such at both the light and the electron 
microscopic levels; Δ, myelinated fiber that can only be identified as such at the 
electron microscopic level). 
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Figure 2.4  Reduced number of primary oligodendrocyte processes in optic 
nerves of tamoxifen-treated Fakflox/flox:PLP/CreERT. A: Total number of cells 
counted at light microscopic level in semithin P14 optic nerve sections at the 1-
mm interval (see Figure 2.2). Mean for all control values was set to 100%, and 
percentages for all data points were calculated accordingly. Bar graph depicts 
means ± SEMs (n = 3 per genotype). B: Number of primary processes per cell 
counted at electron microscopic level and over an entire transverse section for 
each nerve analyzed. Mean for all control values was set to 100%, and 
percentages for all data points were calculated accordingly. Bar graph depicts 
means ± SEMs (n = 3 per genotype, 258 cells for each condition); *, statistically 
significant as determined by the Student's t test. C, D: Representative 
transmission electron micrographs for a Fakflox/flox:PLP/CreERT (D) and a 
Fakflox/flox (C, control) oligodendrocyte. Scale bars = 2 µm. 
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Figure 2.5 Comparable number of myelinated fibers in optic nerves of tamoxifen-
treated Fakflox/flox and Fakflox/flox:PLP/CreERT mice at P28. Numbers of myelinated 
fibers were determined within entire transverse sections of optic nerves at 
approximately 1 mm from the lamina cribosa and as described in Figure 2.2. 
Mean for all control values was set to 100%, and percentages for all data points 
were calculated accordingly. Bar graph depicts means ± SEMs (n = 3 per 
genotype). 
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Chapter 3 
FAK associated mediators of oligodendrocyte cytoskeletal remodeling 
 
Integrins  
Integrins are ubiquitously expressed transmembrane heterodimer 
receptors formed from the combination of one of eighteen possible α chains and 
one of eight possible β chains.  Each subunit (α and β) is composed of a single 
transmembrane domain, to tether the integrin to the membrane, a large 
extracellular domain, which interacts with ECM ligands, and a cytoplasmic 
domain, that interacts with signaling molecules, such as FAK, within the cell 
(Zamir & Geiger 2001, Romer et al. 2006).   
Activation of integrins involves a conformational change which induces 
receptor clustering allowing for further recruitment and activation of focal 
adhesion molecules (Ye et al. 2010, Schwartz & Ingber 1994).  Signaling through 
integrins is a bidirectional process with information traveling in an outside-in 
(signals sent from the extracellular environment are transduced into reactions by 
the cell) or inside-out (signals originating within the cell affect a change in the 
integrin signaling to various other molecules which then leads to other cellular 
reactions) direction (Romer et al. 2006).  One of the signaling molecules most 
commonly activated by integrin signaling is FAK (Buttery et al. 1999).   
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Integrins in developing oligodendrocytes 
 To date five heterodimer pairs of integrins have been shown to be 
expressed on the membranes of oligodendrocytes: α6β1, αvβ1, αvβ3, αvβ5, and 
αvβ8 (Milner & ffrench-Constant 1994, Buttery et al. 1999, Baron et al. 2005).  
The fibronectin/ vitronectin receptor αvβ1 integrin is highly expressed in OPCs 
then declines drastically with differentiation while αvβ3 integrin is most highly 
expressed following OPC differentiation and prior to myelin sheet formation in 
vitro (Milner & ffrench-Constant 1994, Milner et al. 1997, Blaschuk et al. 2000, 
Baron et al. 2005).  Fibronectin and vitronectin along with growth factor signaling, 
such as PDGFα, acting through the αvβ1 integrin receptor enhance OPC 
migration while signaling through αvβ3 integrin is more important for OPC 
proliferation (Lee et al. 2006, Baron et al. 2005).  The other 
fibronectin/vitronectin-binding integrin, αvβ5, replaces the declining αvβ1 integrin 
during early oligodendrocyte differentiation.  The expression of αvβ5 increases 
with differentiation and is found associated with PLP (Milner & ffrench-Constant 
1994, Blaschuk et al. 2000, Gudz et al. 2002).     
Early oligodendrocytes have been shown to contain integrin aggregates 
composed mainly of αvβ3 integrin (Cluzel et al. 2005).  The Lyn SFK associates 
with αvβ3 on OPCs, however there has been little investigation into Lyn’s role 
during oligodendrocyte differentiation and myelination (Klein et al. 2002, 
Colognato et al. 2004).   
 Various in vivo studies have been preformed to elucidate the role of the 
different integrin subunits during oligodendrocyte development.  The most 
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commonly studied subunit is the β1 integrin subunit due to its constitutive 
presence during oligodendrocyte development.  Studies have been contradictory 
until recently.  Region specific myelin deficits and decreases in oligodendrocyte 
differentiation have been reported in mice expressing inactive forms of the β1 
integrin, (Barros et al. 2009, Lee et al. 2006) while in mice with an early knock 
out of β1 expression no myelin defects were reported (Benninger et al. 2006).  
These contradictory findings have been theorized by ffrench-Constant to be due 
to differences in experimental design.  In the inactive β1 expresser studies there 
could be an exaggeration of the phenotype since the inactive integrin might out-
compete other receptors.  While the knockout study could have eliminated β1 
from the system at an early point during development thus allowing 
compensatory mechanisms to take affect.  Due to these possibilities ffrench-
Constant preformed a study in which a dominant negative β1 integrin (a fusion 
protein containing the intracellular β1 domain bound to the nonsignaling human 
interleukin-2 extracellular domain) under control of a later stage oligodendrocyte 
promoter (MBP) was expressed in mice (Camara et al. 2009).  In these mice a 
transient myelin deficit was observed specifically affecting small-diameter fibers 
and a decrease in FAK signaling was seen (Camara et al. 2009).  As mentioned 
in chapter 2 these results were in line with what we had previously observed in 
our FAK-null mice.  These results insinuate a role for integrin signaling, possibly 
through FAK, in initial myelin formation during development.  
Throughout development oligodendrocytes express the α6β1 integrin, 
which binds laminin-2 (Baron et al. 2005).  This integrin receptor is involved in 
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oligodendrocyte survival throughout development, possibly by associating with 
an antigen on the membrane surface of adjacent astrocytes (Gudz et al. 2002, 
Frost et al. 1999, Corley et al. 2001).  The β1 integrin of this heterodimer seems 
to play a large role during myelination, since reducing the expression of β1 
inhibits the activation of Rac and Cdc42 thus inhibiting oligodendrocyte 
morphological maturation and decreasing the number of oligodendrocytes 
exhibiting mature membranes in vitro (Buttery & ffrench-Constant 1999, Liang et 
al. 2004).  Oligodendrocytes grown only on laminin-2 (the substrate for integrin 
α6β1) also have greater process extension and an increased membrane 
formation (Buttery & ffrench-Constant 1999).   
The binding of laminin-2 to α6β1 integrin activates the SFK, Fyn, which is 
expressed by oligodendrocytes throughout development (Grant et al. 1995, Klein 
et al. 2002, Colognato et al. 2004).  Fyn associates with FAK and activates 
p190RhoGAP by tyrosine phosphorylation allowing the upregulation of Cdc42 
and Rac activity, which increases process extension in vitro (Figure 1.2, peach 
pathway) (Wolf et al. 2001, Liang et al. 2004, Cobb et al. 1994, Cary et al. 1996).   
 Fyn is highly expressed in oligodendrocytes during differentiation and 
myelination and is found associated with myelin membrane microdomains (Klein 
et al. 2002, Osterhout et al. 1999, Kramer et al. 1999).  There is increased Fyn 
expression in more differentiated, premyelinating oligodendrocytes than in OPCs 
leading to the conclusion that Fyn may be more functional in process outgrowth 
and myelination than migration and proliferation of oligodendrocytes (Colognato 
et al. 2004).  
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 While Fyn may not be needed for general growth and differentiation, 
without Fyn mice have impaired myelination and a reduced number of 
oligodendrocytes throughout development with less complexity in the 
oligodendrocytes that do survive (Ponniah et al. 1999, Sperber & McMorris 2001, 
Colognato et al. 2004, Sperber et al. 2001, Biffiger et al. 2000).  Fyn null mice 
also have reduced levels of phosphorlyated FAK (Grant et al. 1995).   
It has been shown that β1-integrin inhibition decreases the activity of Fyn 
and disrupts oligodendrocyte differentiation (Liang et al. 2004).  It appears that 
Fyn, activated by association with α6β1 integrin in the focal adhesion, instigates 
FAK’s association with many proteins via tyrosine phosphorylation.  These FAK-
mediated molecular associations activate various proteins including Rac and 
Cdc42 which then lead to increased oligodendrocyte process outgrowth and 
morphologic differentiation (Colognato et al. 2004, Wolf et al. 2001, Liang et al. 
2004).   
 
Extracellular matrix in the CNS  
The ECM is the conglomeration of various molecules, which allow cells to 
respond appropriately to environmental cues primarily via rearrangement of the 
cytoskeleton.  Major constituents of the CNS ECM are hyaluronic acid and 
proteoglycans, as well as tenascins and adhesion-associated ECM molecules, 
such as fibronectin and laminin-2 (Sobel 1998, Bronner-Fraser 1986).  It has 
been well characterized that a change in the ECM environment affects the 
morphology of developing oligodendrocytes (Notterpek & Rome 1994, Fridman et 
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al. 1985, Oh & Yong 1996).  The most well characterized ECM molecules 
involved in oligodendrocyte morphological remodeling are fibronectin and 
laminin-2; therefore we will focus on these two molecules henceforth.   
 In vitro studies have linked fibronectin signaling to enhanced OPC 
proliferation and migration (Hu et al. 2009).  This fibronectin-mediated promotion 
of OPC proliferation requires Lyn activity (Colognato et al. 2004).  Fibronectin is 
also involved in keeping OPCs from differentiating too early during development 
(Hu et al. 2009).  More differentiated oligodendrocytes in association with 
fibronectin have a smaller, less mature process morphology (Olsen & ffrench-
Constant 2005, Liang et al. 2004).  This restriction of the oligodendrocyte 
process network has been shown to involve RhoA activation (Liang et al. 2004).  
The effect of fibronectin on oligodendrocyte process morphology could be due to 
issues with membrane-directed transport since oligodendrocytes plated on 
fibronectin have transport issues that are alleviated when integrin signaling, and 
hence the signaling of fibronectin is blocked (Siskova et al. 2006).   
Laminin-2 is the ECM ligand for two receptors expressed by 
oligodendrocytes, α6β1 integrin and dystroglycan (Colognato et al. 2007, Buttery 
& ffrench-Constant 1999) and is found in direct opposition to unmyelinated axons 
during development (Colognato et al. 2002).  Laminin-2 is involved in growth-
factor induced oligodendrocyte survival and enhanced oligodendrocyte 
differentiation (Baron et al. 2005, Colognato et al. 2002).  The laminin-mediated 
promotion of oligodendrocyte survival and differentiation requires Fyn activity and 
α6β1 integrin function (Colognato et al. 2004, Camara et al. 2009).   
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While fibronectin plays a role in holding oligodendrocytes in a less mature 
morphology laminin-2 is involved in promoting a mature oligodendrocyte process 
morphology and myelin sheath formation (Buttery & ffrench-Constant 1999, 
Olsen & ffrench-Constant 2005, Sypecka et al. 2009).  In vivo animals with 
mutations of laminin-2 have a reduction in oligodendrocyte differentiation and a 
reduced number of myelinated small diameter axon fibers in various regions of 
the CNS (Chun et al. 2003, Relucio et al. 2009).  The laminin-mediated effects on 
oligodendrocyte morphology and myelin formation require integrin-mediated PI3K 
and integrin linked kinase (ILK) activity (Chun et al. 2003).  The laminin-induced 
effect on myelin formation appears to be, at least in part, mediated by the 
dystroglycan receptor, however little is known about the exact effects of laminin-2 
association with dystroglycan receptors (Colognato et al. 2007). Fyn and FAK 
activity have been shown to be enhanced and appears to be required for laminin-
2’s affect on oligodendrocyte morphology and myelination (Relucio et al. 2009, 
Hoshina et al. 2007).   
 Although FAK is a well known integrator of cell-ECM interactions, the 
involvement of FAK in the ECM-mediated effects on oligodendrocyte morphology 
during development, as discussed above, has remained a mystery.  To unravel 
this mystery we utilized an in vitro system which allows for stringent control of the 
oligodendrocyte developmental stage as well as the ECM environment.   
 
 
 
 
 
 
 50
  
Chapter 4 
Focal adhesion kinase (FAK) can play unique and opposing roles in 
regulating the morphological maturation of differentiating oligodendrocyte 
 
(This chapter will be submitted as a paper to the Journal of Neurochemistry.) 
 
Introduction  
 Focal adhesion kinase (FAK), also known as protein tyrosine kinase 2 
(PTK2), is a ubiquitously expressed non-receptor tyrosine kinase that functions 
as an important regulator of cell shape and adhesion in response to 
environmental signals (Mitra et al. 2005, Parsons 2003, Schaller 2010, Hanks & 
Polte 1997, Schlaepfer et al. 1999). In particular, components of the extracellular 
matrix (ECM) are known to interact with transmembrane receptors of the integrin 
family and to subsequently recruit FAK to intracellular multi-molecular 
complexes, termed focal adhesions (Berrier & Yamada 2007, Giancotti & 
Ruoslahti 1999, Geiger et al. 2009, Schaller et al. 1992). FAK-containing focal 
adhesions function as key sensory machineries that integrate extracellular 
signals, interconnect them with the cell’s actin cytoskeleton and thus ultimately 
mediate complex cellular responses. 
In the central nervous system (CNS) FAK expression has long been 
recognized to occur in neurons (Burgaya et al. 1995, Burgaya & Girault 1996, 
Burgaya et al. 1997, Grant et al. 1995, Stevens et al. 1996, Contestabile et al. 
2003). Only more recently, however, its expression was characterized in cells of 
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the oligodendrocyte lineage (Bacon et al. 2007, Kilpatrick et al. 2000). 
Oligodendrocytes, the myelin forming cells of the CNS, undergo extensive 
morphological remodeling when they differentiate from migratory bipolar 
oligodendrocyte precursor cells to post-migratory premyelinating 
oligodendrocytes that extend  a complex process network and finally to mature 
oligodendrocytes that generate the myelin sheath (Pfeiffer et al. 1993, Baumann 
& Pham-Dinh 2001, Jackman et al. 2009). Completing these distinct steps of 
morphological maturation requires extensive remodeling of the cytoskeleton 
(Wang et al. 2008, Bacon et al. 2007, Kim et al. 2006, Miyamoto et al. 2007, 
Sloane & Vartanian 2007, Song et al. 2001, Bauer et al. 2009, Richter-Landsberg 
2008, Southwood et al. 2007, Liang et al. 2004). Thus, FAK, as a key player in 
regulating cytoskeletal organization, is likely involved in the regulation of 
oligodendrocyte differentiation and myelination. Indeed, FAK has been found to 
mediate process outgrowth from cells of the rat-derived oligodendrocyte cell line 
CG4 (Hoshina et al. 2007). In addition, phosphorylation of FAK at its 
autophosphorylation site, which represents a critical event for FAK’s activation 
and catalytic function, has been described to occur primarily in post-migratory 
differentiating oligodendrocytes and to a lesser extent in migratory 
oligodendrocyte progenitor cells, suggesting a role for FAK primarily in maturing 
cells of the oligodendrocyte lineage (Liang et al. 2004). Furthermore, FAK has 
been implicated in a number of signaling pathways regulating oligodendrocyte 
differentiation (Wang et al. 2009, Rajasekharan et al. 2009, Miyamoto et al. 2007, 
Fox et al. 2004). Most importantly, both our lab and ffrench-constant’s lab 
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recently documented that conditional knock-out of FAK in maturing 
oligodendrocytes results in an inhibition and/or delay of normal developmental 
myelination (Camara et al. 2009, Forrest et al. 2009). Taken together, these 
studies highlight the importance of FAK in regulating myelination. However, the 
molecular mechanisms mediated by FAK in maturing oligodendrocytes 
underlying the observed phenotype in the conditional FAK knock-out mice are 
not fully understood. 
 Morphological maturation of cells of the oligodendrocyte lineage occurs in 
the context of a diverse extracellular environment. In particular two ECM proteins 
have been characterized with regard to their importance in oligodendrocyte 
differentiation and myelination, namely fibronectin and laminin-2. Both are 
present in the CNS during the time of normal developmental myelination (see 
Figure 4.7b). Fibronectin has been detected in the developing CNS in a likely 
diffuse manner, while non-basal lamina laminin-2 was found to be present on the 
axonal surface (Tom et al. 2004, Colognato et al. 2002, Zhao et al. 2009). 
Functionally, fibronectin was found to attenuate process outgrowth in 
oligodendrocytes, while laminin-2 has been implicated in stimulating myelin 
sheath formation (Buttery & ffrench-Constant 1999, Chun et al. 2003, Buttery & 
ffrench-Constant 2001, Olsen & ffrench-Constant 2005, Laursen & ffrench-
Constant 2007, Colognato et al. 2005, Siskova et al. 2009, Maier et al. 2005). 
The opposing effects seen in the presence of fibronectin versus laminin-2 raise 
the question of whether either one or both ECM protein’s effects require FAK and 
how these effects may relate to the in vivo phenotype seen in the conditional 
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FAK knock-out mice. 
 In an attempt to better understand the role of FAK, as an integrator of 
ECM signaling, the current study investigated the role of FAK on the 
morphological maturation of post-migratory premyelinating oligodendrocytes in 
the presence of fibronectin and laminin-2 in a well defined in vitro system. The 
data presented here demonstrate the unique and opposing roles of FAK that are 
dependent on the ECM substrate present and on the developmental stage of the 
maturing oligodendrocytes. Thus, these data provide novel insight into the role of 
FAK and they highlight the multi-functionality of FAK in the context of 
developmental myelination.  
 
Materials and methods  
 
Antibodies 
Hybridoma clone A2B5 (ATCC, Manassas, VA) was used for 
immunopanning of oligodendrocyte progenitor cells. Hybridoma clone O4 (gift 
from S. Pfeiffer) was used to identify post-migratory, premyelinating 
oligodendrocytes (Sommer & Schachner 1981, Bansal et al. 1989). Anti-MBP 
(SMI99; Covance, Princeton, NJ) was used for immunostaining.  Anti-laminin 
alpha2, anti-fibronectin, anti-GAPDH, anti-FAK (Millipore, Billerica, MA) anti-Fyn 
and anti-Lyn (Cell Signaling, Beverly MA) antibodies were used for Western 
blots. For all immunostainings, Alexa 594 or 488-conjugated antibodies 
(Invitrogen/Molecular Probes, Carlsbad, CA) were used as secondary antibodies. 
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Horseradish peroxidase (HRP)-labeled secondary antibodies (Vector 
Laboratories, Burlingame, CA) were used for Western blots. 
 
Animals 
Sprague–Dawley female rats with early postnatal litters were obtained 
from Harlan Laboratories (Indianapolis, IN). All animal studies were approved by 
the Institutional Animal Care and Use Committee at Virginia Commonwealth 
University. 
 
Primary Oligodendrocyte cultures                 
Primary rat oligodendrocytes were isolated from postnatal (day 3 or 5) rat 
brains as described previously (Barres et al. 1992, Fox et al. 2003). Briefly, 
cerebral hemispheres were minced and incubated in Hanks balanced salt 
solution supplemented with 0.25% trypsin (Invitrogen, Carlsbad, CA), and 
1 μg/ml DNase (Sigma, St. Louis, MO). After titration, single cells were collected 
by centrifugation, resuspended in Dulbecco's Modified Eagle Medium 
(DMEM)/10% FCS (Invitrogen, Carlsbad, CA) and subjected to A2B5 
immunopanning. Immunopanned cells were plated onto fibronectin (10 μg/ml)-
coated 6-well tissue culture dishes and cultured in serum-free proliferation 
medium (DMEM containing 10ng/ml PDGF (R&D Systems; Minneapolis, MN) 
and 5ng/ml bFGF (Sigma, St. Louis, MO); DMEM/PDGF/bFGF) for 15-20 hrs 
followed by 20-24 hrs in differentiation medium (DMEM containing 40 ng/ml tri-
iodo-thyronine (T3; Sigma, St. Louis, MO) and 1× N2 supplement (Invitrogen, 
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Carlsbad, CA); DMEM/T3/N2).  Cells were then trypsinized and re-plated onto 
the various ECM substrates in the presence of differentiation medium and 
cultured for an additional 20-24 hrs, at which time cells were analyzed.   
 
siRNA-mediated knock-down of FAK expression  
Oligodendrocytes were isolated by A2B5-immunopanning from postnatal 
day 3 or 5 rat brains and plated onto fibronectin (10 μg/ml)-coated 6-well tissue 
culture dishes.  Cells were cultured in serum-free proliferation medium 
(DMEM/PDGF/bFGF) for 15-20 hrs.  Subsequently, cells were switched into 
differentiation medium (DMEM/T3/N2) and siRNA transfected using lipofectamine 
2000 (Invitrogen, Carlsbad, CA).  For siRNA transfection a siGLO green 
transfection indicator along with either a SMARTpool siRNA directed against rat 
FAK or a control non-targeting SMARTpool siRNA, all obtained from Thermo 
Fisher Scientifc/Dharmacon, Inc. (Lafayette, CO), were used.  Transfection 
medium containing siRNA-lipofectamine complexes was replaced with serum-
free differentiation medium (DMEM/T3/N2) after 3 hrs and cells were cultured for 
an additional 15-20 hrs. Subsequently, cells were re-plated onto fibronectin 
(10 μg/ml), laminin-2 (10 μg/ml), or mixed substrate (5 μg/ml fibronectin and 
5 μg/ml laminin-2)-coated glass coverslips and cultured for an additional 15-20 
hrs. No significant reduction in total FAK protein levels was detected at the time 
of replating (data not shown).   
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PF573228-mediated FAK inhibition 
Oligodendrocytes were isolated by A2B5-immunopanning from postnatal 
day 3 or 5 rat brains and plated onto fibronectin (10 μg/ml)-coated 6-well tissue 
culture dishes.  Cells were cultured in serum-free proliferation medium 
(DMEM/PDGF/bFGF) for 15-20 hrs followed by an additional 20-24 hrs in 
differentiation medium (DMEM/T3/N2). Oligodendrocytes were then re-plated 
onto fibronectin (10 μg/ml), laminin-2 (10 μg/ml), or mixed substrate (5 μg/ml 
fibronectin and 5 μg/ml laminin-2)-coated glass coverslips, allowed to settle for 2-
4 hrs and cultured in the presence of a specific inhibitor of FAK’s catalytic activity 
(PF573228 (Tocris Bioscience, Bristol, England) at  100nM or 0.1% DMSO as 
control). Cells were analyzed after an additional 15-20 hrs in culture.  
 
Process morphology analysis            
Process morphology was analyzed as previously described (Dennis et al. 
2008).  siRNA or FAK inhibitor-treated cells along with their respective control 
cells were immunostained with O4 antibodies. For siRNA-treated cells only those 
containing the siGLO green transfection indicator were analyzed.  Images of at 
least 25 cells were taken randomly for each treatment group in each experiment 
(n ≥ 3) using an Olympus BX51 inverted fluorescent microscope (Olympus 
America Inc., Center Valley, PA). IP Lab imaging software (BD Biosciences 
Bioimaging, Rockville, MD) was used to determine process index (total area 
found to be O4-positive minus the cell body) and network area (total area within 
the radius of the process network surrounding the cell body minus the cell body).  
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In addition, the number of primary processes (any process directly extending 
from the cell body) was counted for each cell used for the above process 
morphology analysis.  For the bar graphs representing network areas, process 
indices and primary process number the mean value for cells cultured under 
control conditions was calculated. This mean value was set to 100% and 
adjusted, i.e. normalized, values for all cells were averaged for each 
experimental condition.   
A confocal laser scanning microscopy (TCS SP2 AOBS, Leica 
Microsystems, Exton, PA) was used for the generation of representative images. 
Images represent 2D maximum projections of stacks of 0.4µm optical sections. 
 
Live/Dead Viability Assay 
siRNA or FAK inhibitor-treated cells were assayed for cell viability using 
2µM calcein AM/4µM ethidium homodimer-1 as described by the manufacturer 
(Live/Dead Viability Assay kit, Invitrogen Corp., Carlsbad, CA). Images of 8 fields 
at 10X magnification were taken randomly for each treatment group in each 
experiment (n = 3) using an Olympus BX51 inverted fluorescent microscope 
(Olympus America Inc., Center Valley, PA).  The percentage of live cells (labeled 
with calcein) or dead cells (labeled with ethidium homodimer-1) was analyzed.  
Bar graphs represent the mean value of live or dead cells under each 
experimental condition. 
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Results 
 
For early stage post-migratory premyelinating oligodendrocytes, FAK plays 
unique and opposing roles in regulating morphological maturation in the 
presence of fibronectin versus laminin-2 
The ECM substrates laminin-2 and fibronectin have been previously 
described to differentially affect the maturation of post-migratory premyelinating 
oligodendrocytes (Buttery & ffrench-Constant 1999, Buttery & ffrench-Constant 
2001, Olsen & ffrench-Constant 2005, Siskova et al. 2006, Siskova et al. 2009). 
To assess the effect of these ECM molecules in our tissue culture paradigm, we 
compared network areas and process indices as described previously (Dennis et 
al. 2008). In addition, we analyzed the effect of laminin-2 and fibronectin at two 
developmental stages, namely early and later stage post-migratory 
premyelinating oligodendrocytes. To obtain the early stage oligodendrocytes, 
oligodendrocyte progenitor cells were isolated from postnatal day 3 rat brains by 
A2B5 immunopanning and allowed to differentiate for 20-24 hours before re-
plating onto the different ECM substrates. At the time of immunopanning, 
oligodendrocyte progenitor cells express only the progenitor cell marker 
recognized by the A2B5 antibody (Fox et al. 2004). In contrast, the cells hence 
forth referred to as later stage post-migratory premyelinating oligodendrocytes 
were isolated from postnatal day 5 rat brains by A2B5 immunopanning, at which 
stage the majority of cells express both the early marker recognized by the A2B5 
antibody as well as a later stage surface antigen recognized by the O4 antibody 
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(Fox et al. 2004). As described above, cells were allowed to differentiate for 20-
24 hours before re-plating onto the different ECM substrates. In all cases, cells 
were analyzed after an additional 20-24 hours of culture in differentiation 
medium. 
As shown in Figure 4.1, early stage oligodendrocytes plated on laminin-2 
developed much larger network areas and process indices compared to 
oligodendrocytes plated on fibronectin.  Early stage oligodendrocytes on laminin-
2 revealed an increased occurrence of membrane sheet-like structures as 
denoted by the arrows in Figure 4.1a (right panel).  The later stage post-
migratory premyelinating oligodendrocytes showed a similar effect (network area 
fibronectin: 100%± 7, network area laminin-2: 155%± 10, p<0.05; process index 
fibronectin: 100%± 7, process index laminin-2: 153%± 10, p<0.05) with an even 
more obvious occurrence of membrane sheet-like structures (compare Figure 
4.2c (left panel) with 3c (left panel)). Taken together, these studies demonstrate 
that the effect of fibronectin versus laminin-2 on oligodendrocyte maturation is in 
agreement with previous findings and that the effect of fibronectin versus laminin-
2 on oligodendrocyte maturation occurs for both early and later stage 
oligodendrocytes and . 
One of the major intracellular signaling molecules known to regulate 
cellular morphology is the nonreceptor tyrosine kinase FAK. To determine the 
extent to which FAK may play a role in mediating the differences in 
oligodendrocyte maturation seen in cells plated in the presence of fibronectin or 
laminin-2, early stage post-migratory premyelinating oligodendrocytes were 
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treated with a siRNA pool against FAK or a non-targeting siRNA pool as a 
control. Cells were cultured and analyzed as described above. As shown in 
Figure 4.2a and b, siRNA-mediated FAK knock-down resulted in a significant 
increase in both network area and process index for cells plated in the presence 
of fibronectin. In addition, the number of primary processes was found to be 
increased under these conditions. In contrast, when cells were plated in the 
presence of laminin-2, all three parameters were found to be decreased upon 
siRNA-mediated FAK knock-down (Figure 4.2c and d).  
The effects on cell morphology described above were unlikely due to an 
interference with initial cell spreading, since at the time of re-plating no significant 
differences in FAK protein levels were noted (data not shown). At the time of 
analysis, however, FAK protein levels were found decreased by approximately 
50-60% in cells treated with the FAK-specific siRNA pool as compared to cells 
treated with the control siRNA pool (see Figure 4.7a). It has been previously 
demonstrated that FAK not only acts as a regulator of actin dynamics and cell 
shape but can also be involved in signaling events controlling cell survival (Lim et 
al. 2008a, Westhoff et al. 2004, Mitra et al. 2005, Cox et al. 2006). In addition, 
elevated expression of Pyk2, a cytoplasmic tyrosine kinase closely related to 
FAK, was found to functionally compensate for a loss of FAK and to cause 
alterations beyond effects due to a loss of FAK in certain cell types under some 
circumstances (Weis et al. 2008, Lim et al. 2008b, Sieg et al. 1998). Thus, we 
assessed both cellular viability and Pyk2 protein levels. No significant differences 
were observed at the time of analysis (see Figures 4.7a and 4.8a). These 
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findings suggest that FAK regulates morphological maturation of post-migratory 
premyelinating oligodendrocytes without a significant change in cell viability or a 
considerable compensatory increase in Pyk2 expression   
 During normal development morphological maturation of the 
oligodendrocyte’s process network occurs concurrently with the establishment of 
a protein expression profile characteristic for mature oligodendrocytes (Hardy et 
al. 1996, Emery et al. 2009, Dugas et al. 2006). Under experimental conditions, 
however, an independent regulation of these two processes has been observed 
indicating that morphological and gene expression profile maturation may be 
regulated by distinct molecular mechanisms (Buttery & ffrench-Constant 1999, 
Osterhout et al. 1999, Sloane & Vartanian 2007, Younes-Rapozo et al. 2009). To 
assess the extent to which the effect of siRNA-mediated FAK knock-down on cell 
morphology was associated with a change in the oligodendrocyte’s protein 
expression profile, the number of cells expressing one of the most extensively 
studied proteins associated with oligodendrocyte maturation, namely myelin 
basic protein (MBP), was determined. As shown in Figure 4.2e and f, no 
significant changes in the number of the MBP-expressing cells were noted under 
either of the conditions analyzed.  
Thus, the above data demonstrate that FAK can regulate the morphology 
of the early stage post-migratory premyelinating oligodendrocyte’s process 
network in a unique and opposing manner depending on the ECM substrate 
present. In particular, FAK limits the maturation of the oligodendrocyte’s process 
network in the presence of fibronectin, while it promotes process maturation in 
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the presence of laminin-2. In both cases, this regulation appears to be 
independent of survival and/or the expression of myelin proteins.  
 
For later stage post-migratory premyelinating oligodendrocytes, 
morphological maturation is significantly less dependent on FAK in the 
presence of fibronectin but still remains significantly controlled by FAK in 
the presence of laminin-2 
Our previous in vivo data demonstrated a significant decrease in the 
number of primary processes upon induction of FAK knock-out; an effect 
resembling the one seen in the presence of laminin-2 but not fibronectin for the 
early stage post-migratory Premyelinating oligodendrocytes (Figure 4.2c and d). 
The in vivo data were obtained from P14 optic nerves and thus at more 
advanced developmental stages than those analyzed in Figure 4.2. Based on 
these observations, we hypothesized that the role of FAK in regulating the 
oligodendrocyte’s process network may change during developmental 
maturation. To investigate this hypothesis, we treated and analyzed later stage 
differentiating oligodendrocytes (isolated from postnatal day 5 rat brain) as 
described above. Compared to the early stage post-migratory premyelinating 
oligodendrocytes, the later stage cells were found to express similar levels of 
FAK mRNA and protein (our unpublished data and (Dugas et al. 2006)). In 
addition, there was no significant difference in the efficiency of siRNA-mediated 
FAK knock-down between the two stages of oligodendrocytes (Figure 4.7a). 
Furthermore, as observed for the early stage post-migratory premyelinating 
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oligodendrocytes, viability and Pyk2 expression remained unchanged in the later 
stage cells upon siRNA-mediated FAK knock-down (Figures 4.7b and 4.8b).   
 Unlike the early cells, however, there was no discernable change in the 
later stage post-migratory Premyelinating oligodendrocyte’s process network 
morphology in the presence of fibronectin upon siRNA-mediated FAK knock-
down (Figure 4.3a and b). In contrast, in the presence of laminin-2 the later stage 
differentiating oligodendrocytes displayed a similar change in the process 
network morphology as seen for the early stage post-migratory premyelinating 
oligodendrocytes (compare Figure 4.2c and d with Figure 4.3c and d). As was 
observed for the early stage oligodendrocytes there was no notable change in 
the number of MBP expressing oligodendrocytes under either of the conditions 
(Figure 4.2e and f and 4.3e and f).   
 The above data demonstrate that with developmental maturation, FAK 
looses its capacity to and/or effectiveness in regulating the process network 
morphology of post-migratory pre-myelinating oligodendrocytes in the presence 
of fibronectin. FAK’s role in enhancing process network morphology in the 
presence of laminin-2, however, appears to remain unchanged.  
  
For early stage post-migratory premyelinating oligodendrocytes, FAK’s 
constraining role for morphological maturation appears to predominate 
while for later stage oligodendrocytes FAK’s stimulatory role seems to 
prevail 
Both, fibronectin and laminin-2 have been found present in the developing 
 64
  
CNS during oligodendrocyte maturation (Figure 4.8g and (Fox et al. 2004, 
Colognato et al. 2002, Tom et al. 2004). Thus, we wished to determine the role of 
FAK for the morphological maturation of post-migratory premyelinating 
oligodendrocytes under conditions in which both fibronectin and laminin-2 are 
present in the environment. Early and later stage post-migratory premyelinating 
oligodendrocytes were cultured, treated and analyzed as described above, with 
the exception that cells were re-plated on a mixed substrate of equal 
concentrations of fibronectin and laminin-2 (instead of the individual substrates). 
Interestingly, even though FAK was found to regulate morphological maturation 
of early stage post-migratory premyelinating oligodendrocytes in an opposing 
manner on fibronectin versus laminin-2, its role on the mixed substrate appeared 
to be a primarily constraining one, i.e. similar to the one observed on fibronectin 
alone (Figure 4.4a and b). For the later stage post-migratory premyelinating 
oligodendrocytes, in which FAK appeared to have lost its capacity and/or 
effectiveness in regulating the process network morphology in the presence of 
fibronectin, the role of FAK was expectedly a stimulatory one, i.e. similar to the 
one seen on laminin-2 alone (Figure 4.4c and d).  
These data suggest that during the developmental maturation of post-
migratory premyelinating oligodendrocytes FAK’s role switches from a 
predominantly morphology restraining to a mostly morphology enhancing one.  
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FAK’s unique and opposing roles in regulating morphological maturation 
of post-migratory premyelinating oligodendrocytes are mediated by its 
catalytic activity 
FAK’s role in regulating morphological remodeling in various cell types has 
at least in vitro been well documented to depend on its catalytic activity, i.e. 
autophosphorylation (Parsons 2003, Hanks et al. 2003, Playford & Schaller 2004, 
Schlaepfer et al. 1999, Cary et al. 1996). However, recent in vitro and in vivo 
studies highlight the importance of both catalytic-dependent and catalytic-
independent mechanisms in mediating FAK’s physiological functions (Corsi et al. 
2009, Lim et al. 2008a, Cance & Golubovskaya 2008). To assess the extent to 
which the above described effects of FAK in oligodendrocyte maturation were 
dependent on its catalytic activity, we used the FAK kinase inhibitor PF573228. 
This inhibitor has been shown in a variety of cell types to effectively block FAK 
autophosphorylation and downstream signaling without significantly affecting cell 
survival (Slack-Davis et al. 2007, Chen et al. 2009). Thus, to prevent potential 
effects of initial cell spreading differentiating oligodendrocytes were treated with 
PF573228 following re-plating. As described previously, treatment with 
PF573228 did not significantly affect the viability of differentiating 
oligodendrocytes (see Figure 4.9).  
 As shown in Figure 4.5, for both early and later stage post-migratory 
premyelinating oligodendrocytes treatment with PF573228 resulted in changes in 
cell morphology similar to the ones seen upon FAK knock-down. A concentration 
of 100 nM was reported to yield approximately half-maximal inhibition of FAK 
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autophosphorylation in various cell types (Slack-Davis et al. 2007). Thus, in both 
paradigms, siRNA-mediated FAK knockdown and PF573228 pharmacological 
inhibition, residual FAK activity likely remains. These data, therefore, suggest 
that a significant downregulation of FAK expression and/or FAK catalytic activity 
is sufficient to block the majority of FAK’s roles in regulating morphological 
maturation of differentiating oligodendrocytes. Interestingly, however, for later 
stage post-migratory pre-myelinating oligodendrocytes treatment with PF573228 
in the presence of fibronectin resulted in a slight increase in the number of 
primary processes, while network area and process index remained unchanged. 
FAK’s role in limiting initial process outgrowth in later stage post-migratory pre-
myelinating oligodendrocytes in the presence of fibronectin seems to be 
particularly sensitive to the inhibition of FAK’s catalytic activity.  
 
Discussion 
The current study demonstrates that FAK can regulate morphological 
maturation of post-migratory premyelinating oligodendrocytes in a unique and 
opposing fashion that is dependent on the nature of the ECM substrate present 
(i.e. fibronectin or laminin-2) and that is, for the most part, mediated by FAK’s 
catalytic activity. In addition, the regulatory role of FAK in the morphological 
maturation of post-migratory premyelinating oligodendrocytes was found to be 
tightly regulated with the cell’s stage of maturation. More specifically, for the early 
stage post-migratory premyelinating oligodendrocytes FAK’s constraining role on 
morphological maturation predominated, while its stimulatory role prevailed for 
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the later stage oligodendrocytes (see Figure 4.6). Taken together, the data 
presented here provide novel insight into the complex role that FAK plays in 
regulating the morphological maturation of differentiating oligodendrocytes in the 
context of developmental changes and spatial differences in the molecular 
composition of the extracellular environment. 
FAK’s role in limiting the establishment of an expanded process network in 
the presence of fibronectin was found to be significantly diminished for later 
stage post-migratory premyelinating oligodendrocytes (see Figure 4.6). 
Fibronectin receptors αvβ1, αvβ3, αvβ5 and αvβ8 integrins are expressed and 
present on the surface of oligodendrocytes at all developmental stages (Milner & 
ffrench-Constant 1994, Milner et al. 1997, Cahoy et al. 2008, Dugas et al. 2006). 
Thus, while the functional role of FAK in the presence of fibronectin likely 
involves the activation of integrin type receptors, it seems unlikely that a reduced 
expression of fibronectin receptors is the primary cause of the observed 
reduction in FAK-mediated function for the later stage cells. It, therefore, appears 
to be the signaling pathway downstream of FAK that is altered in the more 
mature cells. Due to the complex nature of FAK-containing signaling complexes, 
multifaceted studies will be necessary to better understand the molecular 
mechanism responsible for the developmental difference observed here.  
Interestingly, it has been previously reported that FAK can also limit the 
size of the axonal arbor for a variety of neuronal cell types (Rico et al. 2004). In 
addition, FAK has been found to limit the length and number of dendritic 
protrusions (Moeller et al. 2006, Shi et al. 2009). Both functions of FAK were 
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found to be, at least in part, dependent on FAK’s catalytic activity. Most 
importantly, FAK was implicated in controlling the establishment of the final 
pattern of connections between neurons and their targets by enabling efficient 
pruning of overproduced and/or ‘weak’ connections. With regard to the findings 
described here, it is, therefore, tempting to speculate that the process network 
limiting function of FAK observed in the presence of fibronectin, an ECM 
molecule that is expressed broadly during development, allows for efficient 
pruning of ‘non-functional’ oligodendroglial processes and represents part of the 
regulatory mechanism that determines the final number of myelinated segments 
that are generated by an individual mature oligodendrocyte.  
In contrast to FAK’s process network limiting role discussed above, its role 
in stimulating the establishment of a more mature morphology in the presence of 
laminin-2 remained unchanged during the maturation of post-migratory 
premyelinating oligodendrocytes and was thus found to predominate for the later 
stage cells. Due to the more restricted presence of laminin-2 on the axonal 
surface (Colognato et al. 2002), this function of FAK may play a more spatially 
confined role than the one seen in the presence of fibronectin. Notably, the 
interaction between laminin-2 and the integrin receptor α6β1 has been well 
demonstrated to be involved in regulating the morphological maturation of post-
migratory premyelinating oligodendrocytes in vitro and in vivo (Camara et al. 
2009, Lee et al. 2006, Buttery et al. 1999, Barros et al. 2009, Relvas et al. 2001, 
Olsen & ffrench-Constant 2005, Chun et al. 2003, Colognato et al. 2002, Laursen 
& ffrench-Constant 2007). Most importantly, hypomyelinating phenotypes 
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observed upon reducing α6β1 integrin signaling in maturing oligodendrocytes 
resemble those seen upon inducing FAK knock-out in maturing oligodendrocytes 
(Camara et al. 2009, Forrest et al. 2009). Thus, in the presence of laminin-2 FAK 
likely functions as a downstream target of laminin-2-α6β1 integrin interactions. In 
addition to regulating morphological maturation of differentiating 
oligodendrocytes laminin-2-α6β1 integrin interactions have been described to 
promote the transition from oligodendrocyte progenitor cells to mature MBP-
expressing oligodendrocytes and to enhance survival of oligodendrocytes in 
response to limiting concentrations of growth factors (Colognato et al. 2007, 
Frost et al. 1999, Baron et al. 2005, Colognato et al. 2002). However, no 
significant changes in the number of MBP-expressing or surviving cells were 
noted in the studies presented here. These finding are in agreement with the 
data obtained from conditional FAK knock-out mice, in which no obvious changes 
in the number of cells were noted (Forrest et al. 2009). Thus, FAK is unlikely to 
play a significant role in regulating myelin protein gene expression and/or survival 
for post-migratory premyelinating oligodendrocytes as a downstream target of 
laminin-2-α6β1 integrin interactions. This interpretation may be supported by the 
discovery that the src family kinase (SFK) regulatory proteins Csk and Cbp are 
critically involved in mediating the transition from oligodendrocyte progenitor cells 
to MBP-expressing oligodendrocytes downstream of laminin-2-α6β1 integrin 
interactions (Colognato et al. 2004, Relucio et al. 2009). Taken together, these 
findings, therefore, strongly suggest a crucial role of FAK in regulating the 
morphological maturation of post-migratory premyelinating oligodendrocytes by 
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functioning as a downstream target of spatially restricted laminin-2-α6β1 integrin 
interactions that affect the organization of the cell’s cytoskeleton. Interestingly, 
dystroglycan has been recently identified as a second laminin receptor 
functionally involved in promoting oligodendrocyte maturation and myelination 
(Colognato et al. 2007). However, knock-down of dystroglycan was found to 
significantly affect both myelin gene expression as well as morphological 
maturation of oligodendrocytes. Thus, it is unclear to what extent laminin-2-
dystroglycan interactions may contribute to the FAK-mediated mechanism 
described here. 
The role of FAK in regulating oligodendrocyte morphology in the presence 
of both fibronectin and laminin-2 was seen to be largely dependent on FAK’s 
catalytic activity. Phosphorylation of FAK at its autophosphorylation site creates a 
high affinity binding site for Src-homology 2 (SH2) domain containing proteins, in 
particular SFKs (Mitra et al. 2005, Mitra & Schlaepfer 2006, Parsons 2003, Cobb 
et al. 1994).  The binding of SFKs to FAK can lead to the formation of a FAK-
activated SFK complex, which has the capability to act as a regulator of cell 
shape. In addition, it has been demonstrated that FAK can directly phosphorylate 
SFKs at their Y418 activation site (Wu et al. 2008). Two SFKs have been 
described to be expressed at significant levels in maturing oligodendrocytes, 
namely Fyn and Lyn (Colognato et al. 2004, Osterhout et al. 1999, Kramer et al. 
1999). In agreement with these studies, both Fyn and Lyn were found expressed 
in post-migratory premyelinating oligodendrocytes at the maturation stages 
analyzed here (see Figure 4.8c-f). The SFK Fyn has been well documented to be 
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involved in regulating morphological maturation of differentiating 
oligodendrocytes via the laminin-2-α6β1 integrin pathway (Colognato et al. 2004, 
Relucio et al. 2009). Taken together with the data presented here, morphological 
maturation of post-migratory premyelinating oligodendrocytes appears to be 
mediated by the concerted action of FAK and Fyn as downstream targets of 
laminin-2-α6β1 integrin interactions  (see also (Hoshina et al. 2007). In contrast 
to the laminin receptor α6β1 integrin, which has been shown to associate with 
Fyn, the fibronectin receptor αvβ3 integrin was found to associate with the SFK 
Lyn and not Fyn (Colognato et al. 2004). This association has been functionally 
implicated in the regulation of PDGF-mediated oligodendrocyte progenitor cell 
proliferation. The data presented here, could indicate an additional role, i.e. a role 
in negatively regulating the morphological maturation of post-migratory 
premyelinating cells via a fibronectin-αvβ3 integrin-FAK-Lyn pathway.  
The current study provides novel insight into the complex and diverse 
roles that FAK can play in regulating the morphological maturation of post-
migratory premyelinating oligodendrocytes. In vivo FAK knock-out was found to 
lead to a delay in myelination, a phenotype that is associated with a reduction in 
the number of primary oligodendroglial processes (Camara et al. 2009, Forrest et 
al. 2009). Based on the data presented here, this phenotype appears, at least in 
part, to be due to a lack of FAK’s maturation promoting role in the presence of 
laminin-2. In the context of demyelinating diseases, such as Multiple Sclerosis, 
FAK, therefore, presents itself as a good therapeutic target for promoting 
remyelination. However, demyelinated lesions are characterized by an 
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extracellular environment that is different from the one found in the developing 
CNS. In particular, high levels of fibronectin were noted in lesions of Multiple 
Sclerosis patients (Satoh et al. 2009, van Horssen et al. 2007, Sobel & Mitchell 
1989). Thus, FAK signaling may, at least in part, contribute to the limited repair 
seen in such lesions. Taken together, the findings presented here highlight the 
complexity of FAK’s role in regulating the maturation of post-migratory 
premyelinating oligodendrocytes, and they emphasize the importance of a better 
understanding of the signaling pathways involving FAK in order to be able to 
design effective therapeutic strategies for promoting remyelination under 
pathological demyelinating conditions.  
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Figure 4.1 Morphological maturation of post-migratory premyelinating 
oligodendrocytes is uniquely regulated in the presence of fibronectin or laminin-2. 
Oligodendrocyte progenitor cells were isolated by A2B5 immunopanning from 
postnatal day 3 rat brains. After 2 days in culture, differentiating oligodendrocytes 
were re-plated onto fibronectin (Fn) or laminin-2 (Ln)-coated glass coverslips and 
allowed to differentiate for 20-24 hours. (a) Representative images of cells 
stained with the O4 antibody.  (b) Bar graphs depicting quantitative analyses of 
the total area occupied by the cells’ process network (network area; left graph) 
and the total area of O4-positive process surfaces per cell (process index; right 
graph). Mean control network areas and process indices were set to 100% and 
all values were adjusted accordingly. Means and standard errors are shown. 
Four independent experiments were performed and 25 cells per experiment were 
analyzed. For both parameters, Student’s t-test analysis revealed an overall two-
tailed significance level of p<0.05 (indicated by the star).  Scale Bar: 20 μm. 
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Figure 4.2 siRNA-mediated knock-down of FAK expression affects 
morphological maturation of early stage post-migratory premyelinating 
oligodendrocytes distinctively and in an opposing fashion in the presence of 
fibronectin or laminin-2. Cells were isolated, differentiated and analyzed as 
described in Figure 4.1. Cells were, however, treated with a control siRNA pool 
(siControl) or a siRNA pool against FAK (siFAK) 15-20 hours after initial plating. 
(a) Representative images of cells stained with the O4 antibody and plated in the 
presence of fibronectin (Fn). (b) Bar graphs representing quantitative analyses of 
network areas, process indices and primary process numbers of cells plated in 
the presence of fibronectin (Fn).  (c) Representative images of cells stained with 
the O4 antibody and plated in the presence of laminin-2 (Ln). (d) Bar graphs 
representing quantitative analyses of network areas, process indices and primary 
process numbers of cells plated in the presence of laminin-2 (Ln). (e) 
Representative images of cells stained with an antibody specific for myelin basic 
protein (MBP) (left panels) and with Hoechst to visualize nuclei (left panels). (e) 
Bar graph representing the percentage of Hoechst-positive cells that are also 
MBP-positive. In all bar graphs, means and standard errors of at least three 
independent experiments (25 cells each for all conditions) are shown. Stars 
indicate an overall two-tailed significance level of p<0.05 as determined by 
Student’s t-test analysis. Scale Bars: 20 μm (in a and b), 50 μm (in e).  
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Figure 4.2 
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Figure 4.3 siRNA-mediated knock-down of FAK expression fails to affect 
morphological maturation of later stage post-migratory premyelinating 
oligodendrocytes in the presence of fibronectin but still affects maturation in the 
presence of laminin-2. Later stage oligodendrocytes were isolated, differentiated, 
treated and analyzed as described in Figure 4.2. (a) Representative images of 
cells stained with the O4 antibody and plated in the presence of fibronectin (Fn). 
(b) Bar graphs representing quantitative analyses of network areas, process 
indices and primary process numbers of cells plated in the presence of 
fibronectin (Fn).  (c) Representative images of cells stained with the O4 antibody 
and plated in the presence of laminin-2 (Ln). (d) Bar graphs representing 
quantitative analyses of network areas, process indices and primary process 
numbers of cells plated onto laminin-2 (Ln) as substrate. (e) Representative 
images of cells stained with an antibody specific for myelin basic protein (MBP) 
(left panels) and with Hoechst to visualize nuclei (left panels). (e) Bar graph 
representing the percentage of Hoechst-positive cells that are also MBP-positive. 
In all bar graphs, means and standard errors of at least three independent 
experiments (25 cells each for all conditions) are shown. Stars indicate an overall 
two-tailed significance level of p<0.05 as determined by Student’s t-test analysis. 
Scale Bars: 20 μm (in a and b), 50 μm (in e).  
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Figure 4.3 
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Figure 4.4 siRNA-mediated knock-down of FAK expression in the presence of a 
mixed fibronectin/laminin-2 substrate affects morphological maturation of early 
and later stage post-migratory premyelinating oligodendrocytes in a distinctive 
and opposing fashion. Cells were isolated, differentiated, treated and analyzed 
as described in Figure 4.2. (a,c) Representative images of cells stained with the 
O4 antibody. Early stage post-migratory premyelinating oligodendrocytes are 
shown in (a), while (c) depicts later stage cells. Scale Bars: 20 μm. (b,d). Bar 
graphs representing quantitative analyses of network areas, process indices and 
primary process numbers. Means and standard errors of at least three 
independent experiments (25 cells each for all conditions) are shown. Stars 
indicate an overall two-tailed significance level of p<0.05 as determined by 
Student’s t-test analysis.  
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Figure 4.5 Inhibition of FAK’s catalytic activity affects morphological maturation 
of early and later stage post-migratory premyelinating oligodendrocytes in a 
similar fashion as siRNA-mediated knock-down of FAK expression. Cells were 
isolated, differentiated and analyzed as described in Figures 4.1. Cells were, 
however, treated with the FAK inhibitor PF573228 (PF228; 100 nM)) or vehicle 
(control; 0.1% DMSO) (a,b). Bar graphs representing quantitative analyses of 
network areas, process indices and primary process number of early (in a) and 
later (in b) stage post-migratory premyelinating oligodendrocytes in the presence 
of fibronectin (Fn) or laminin-2 (Ln). Means and standard errors of at least three 
independent experiments (25 cells each for all conditions) are shown. Stars 
indicate an overall two-tailed significance level of p<0.05 as determined by 
Student’s t-test analysis.  
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Figure 4.6 Proposed model for the role of FAK in morphological maturation of 
post-migratory premyelinating oligodendrocytes. The data presented here 
demonstrate that FAK can have unique and opposing roles depending on the 
maturation stage of the cell and the nature of the prevalent ECM molecule that 
the cell encounters. In early stage post-migratory pre-myelinating 
oligodendrocytes FAK is involved in restraining morphological maturation in the 
presence of fibronectin, while it promotes maturation in the presence of laminin-
2. Based on the mixed substrate data, it is the restraining role of FAK that 
predominates in these early stage cells. In the later stage post-migratory pre-
myelinating oligodendrocytes FAK’s role in restraining morphological maturation 
in the presence of fibronectin is significantly diminished or even lost. FAK’s 
maturation promoting role, however, still remains active. Taken together, these 
data uncover the complexity of FAK’s role in the regulation of morphological 
maturation of post-migratory premyelinating oligodendrocytes and they suggest 
that proper oligodendrocyte maturation requires a well coordinated balance 
between maturation restraining and promoting mechanisms.  
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Figure 4.7 siRNA treatment of differentiating oligodendrocytes reduces FAK 
protein levels without significantly affecting cell viability.  (a-b) Bar graphs 
representing FAK protein levels as determined by Western blot analysis for early 
(a) or later stage (b) post-migratory premyelinating oligodendrocytes treated with 
a siRNA pool against FAK (siFAK) or a non-targeting siRNA pool as control 
(siControl) in the presence of fibronectin (Fn) or laminin-2 (Ln). Protein levels 
were quantified using enhanced chemiluminescence (ECL) detection in 
combination with VersaDoc imaging and the use of the QuantityOne software 
package (BioRad Laboratories, Hercules CA). GAPDH protein levels were used 
for normalization. A representative Western blot is shown in the inset in (a). 
Dashed lines represent control levels of FAK protein, which were set to 100% for 
each condition. The efficiency of the siRNA transfection for all conditions was 
approximately 70% (data not shown). (c-d) Bar graphs representing the 
percentage of enzymatically converted calcein AM-positive (live; black bars) or 
ethidium homodimer-positive (dead; grey bars) cells following treatment with a 
siRNA pool against FAK (siFAK) or control siRNA pool (siControl) in the 
presence of fibronectin (Fn) or laminin-2 (Ln). In (c) the results for early stage 
post-migratory premyelinating oligodendrocytes are shown, whereas in (d) the 
results for the later stage cells are depicted. In all bar graphs, means and 
standard errors of at least three independent experiments (25 cells each per 
condition) are shown. Stars indicate an overall two-tailed significance level of 
p<0.05 as determined by Student’s t-test analysis.  
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Figure 4.7 
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Figure 4.8 The protein levels of the non-receptor tyrosine kinase family member 
Pyk2 (a and b) and the src kinases Fyn (c and d) and Lyn (e and f) are not 
significantly affected upon siRNA-mediated FAK knock-down. Total cell 
homogenates were prepared from early (a, c and e) and late stage (b, d and f) 
post-migratory premyelinating oligodendrocytes, treated with a siRNA pool 
against FAK (siFAK) or control siRNA pool (siControl) and plated on fibronectin 
(Fn) or laminin-2 (Ln).  Cell lysates were analyzed by Western blot analysis as 
described in Figure 4.7 and normalized to GAPDH.  Representative Western 
blots of the later stage oligodendrocytes plated on laminin-2 are shown in the 
insets in (b, d, and f). Dashed lines represent control levels of protein, which 
were set to 100% for each condition.  Densitometrical measurements were 
analyzed for at least three independent experiments (p values are indicated in 
white on each bar). g) Both fibronectin and laminin-2 are present in vivo in the 
mouse optic nerve at developmental time points when oligodendrocyte 
maturation and myelination occur. Whole tissue homogenates were prepared 
from postnatal day (P) 2, 5, 14 and 30 optic nerves. Homogenates were analyzed 
using Western blots as described in Figure 4.7  
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Figure 4.8 
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Figure 4.9 Inhibition of FAK’s catalytic activity using the inhibitor PF573228 does 
not significantly affect the viability of early and later stage post-migratory pre-
myelinating oligodendrocytes.  Bar graphs representing the percentage of 
enzymatically converted calcein AM-positive (live; black bars) or ethidium 
homodimer-positive (dead; grey bars) cells following treatment with PF573228 
(PF288) or vehicle (control) in the presence of fibronectin (Fn) or laminin-2 (Ln). 
In all bar graphs, means and standard errors of at least three independent 
experiments (25 cells each per condition) are shown. Stars indicate an overall 
two-tailed significance level of p<0.05 as determined by Student’s t-test analysis.  
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Chapter 5 
Final conclusions 
Various pathological conditions affect the oligodendrocyte’s myelin sheath 
and hence disrupt the ability of axonal signals to be communicated effectively 
leading to a multitude of devastating symptoms.  As discussed in chapter one the 
most prevalent primary demyelinating pathology of the CNS in humans is MS.  
While there are premyelinating oligodendrocytes found in at least some MS 
lesion, their final maturation appears blocked and there is little to no successful 
remyelination (Chang et al. 2002, Kuhlmann et al. 2008).  Due to the lack of 
remyelination in pathologies involving oligodendrocyte and myelin sheath 
destruction, identifying potential targets that will enhance the derelict 
endogenous remyelination could lead to potential cures for these pathologies.  In 
order to fully understand the optimal therapeutic targets that will promote 
remyelination in pathologies, such as MS, it is first essential to understand the 
factors involved in developmental oligodendrocyte maturation and myelination.   
Throughout development oligodendrocytes undergo many drastic 
morphological metamorphoses; developing from bipolar OPCs into highly 
complex premyelinating oligodendrocytes and finally into fully myelinating mature 
oligodendrocytes.  Such extreme morphological remodeling requires drastic 
cytoskeletal rearrangement.  FAK is a known leading regulator of cytoskeletal 
rearrangement and hence an ideal candidate for further exploration into its role 
during developmental oligodendrocyte morphological maturation.   
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In vivo analysis of FAK during initial CNS myelination  
In order to ascertain if FAK is involved in later stage oligodendrocyte 
morphological maturation and initiation of myelination, temporally-regulated 
oligodendrocyte-specific FAK knockout mice were analyzed (Figure 2.1).  These 
studies demonstrate that during development FAK expression is required for 
appropriate initiation of myelination.  Mice lacking FAK in oligodendrocytes during 
later stages of morphological remodeling and initiation of myelination have fewer 
myelinated fibers than control littermates (Figure 2.2).  The hypomyelinating 
phenotype without FAK expression in oligodendrocytes was also observed by 
ffrench-Constant’s group, finding that this phenomenon is primarily restricted to 
the small diameter axonal fibers during initiation of myelination in conditional 
knockout mice (FAKflox/flox; CNP/Cre) (Camara et al. 2009).  This additional 
information is of interest since the small diameter axonal fibers are the last to be 
myelinated during normal development (Hildebrand & Waxman 1984, Fraher et 
al. 1988, Schwab & Schnell 1989).   
We further explored the possible explanations for this hypomyelination 
and discovered that the reduction in myelinated axonal fibers could be due to 
inappropriate morphological remodeling of the oligodendrocyte process network 
prior to and during initial myelination.   FAK null oligodendrocytes have a reduced 
number of primary processes (Figure 2.4).  These data could indicate that normal 
myelination can progress to a point at which time the resources of the FAK null 
oligodendrocyte are depleted and the last fibers to be myelinated, the small 
diameter fibers, are left unmyelinated.  Alternatively this could involve the relation 
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of axonal diameter size to the number of internodal segments myelinated by a 
single oligodendrocyte, i.e. that oligodendrocytes that myelinate large diameter 
axons myelinate fewer internodal segments than those that myelinate small 
diameter fibers (Butt & Ransom 1989, Remahl & Hilderbrand 1990).  Due to the 
reduction in the number of primary processes the FAK-null oligodendrocytes 
could be ideal for myelinating the larger diameter fibers, however, they might not 
have the required number of processes to efficiently myelinate the small diameter 
axon’s internodal segments.   
In both oligodendrocyte-specific FAK-null mouse systems myelin appears 
normal in the adults suggesting a transient effect in which the timing of 
myelination is negatively affected (Figure 2.5 (Camara et al. 2009)).  The normal 
myelination seen in the adult FAKflox/flox; CNP/Cre mice could be due to early 
knock-out of FAK under the CNP promoter.  The early elimination of FAK from 
oligodendrocytes could allow for the upregulation of a compensatory mechanism 
that could repair the initial hypomyelination observed leading to the transient 
phenotype.  One of the main candidates for such a compensatory mechanism is 
Pyk2 since it is highly expressed in the brain as well as being expressed in 
oligodendrocytes (Figure 4.8) and is the only other family member of the non-
receptor tyrosine kinase family (Menegon et al. 1999).  Pyk2, however, has been 
shown incapable of replacing all of the functions FAK fulfills, including those 
involved in cytoskeletal dynamic regulation (Schlaepfer et al. 1999, Klingbeil et 
al. 2001).  The levels of Pyk2 are also shown to be upregulated in MS lesions 
weakening the idea that Pyk2 could effectively compensate for FAK and promote 
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normal myelination since it is highly expressed during a pathological condition in 
which remyelination is limited (Comabella & Martin 2007).   
A more likely candidate involved in a possible compensatory mechanism 
would be ILK, which is associated with focal adhesion molecules and is 
expressed in the CNS (Chun et al. 2003, Wu & Dedhar 2001).  ILK has also been 
shown to be involved in myelin sheet formation in vitro; dominant negative ILK 
reduces the formation of myelin sheets on the permissive laminin-2 ECM 
substrate (Chun et al. 2003).  Therefore ILK could signal to many of the 
molecules also regulated by FAK and could compensate for FAK function in 
myelin formation providing that it is activated at an early enough time point.   
Our system also displays proper myelination in the adult, an effect that 
could possibly be due to the timing of induced FAK knock-out rather than 
reflecting a transient effect.  To remain consistent with the developmental 
studies, tamoxifen injections, and thus induction of FAK knock-out, were carried 
out from P2 through P14 allowing tamoxifen to be flushed from the system 
around P16-17, a time point at which myelination is still highly active in the optic 
nerve.   Without tamoxifen in the system Cre recombinase is unable to 
translocate to the nucleus effectively inhibiting FAK knockout in oligodendrocytes 
derived following tamoxifen elimination.  A second wave of oligodendrocytes, 
expressing normal levels of FAK, could have migrated to the areas of 
hypomyelination and myelinated any of the small diameter fibers that the FAK 
null oligodendrocytes were unable to myelinate, effectively repairing the 
hypomyelinating phenotype (Colello et al. 1994, Kessaris et al. 2006).   
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Currently the exact nature of possible compensatory mechanisms is 
unknown.  The most elegant way to asses the actual role of FAK throughout 
development, from oligodendrocyte morphological maturation through myelin 
maintenance, would be to continue tamoxifen injections in our inducible FAK null 
mice throughout adulthood, thus eliminating the possibility of any unaffected 
oligodendrocytes repairing the hypomyelinated region.  Additional studies in 
which the timing of tamoxifen injection is altered to target the development of 
oligodendrocytes in other CNS regions could also determine whether the effect of 
FAK on oligodendrocyte initial myelination is ubiquitous throughout the CNS or is 
region specific. 
 
In vitro analysis of FAK in post-migratory premyelinating oligodendrocyte 
morphological maturation  
Since we discovered that inappropriate oligodendrocyte morphological 
remodeling could be responsible for the hypomyelination observed during initial 
myelination in vivo we began exploring the possibility that FAK could be involved 
in oligodendrocyte morphological maturation leading up to myelination.  To 
further elucidate FAK’s role during oligodendrocyte morphological remodeling 
prior to myelination we utilized an in vitro system which allowed for strict 
regulation of both the environment and developmental stage of the 
oligodendrocytes analyzed.   
These studies revealed that FAK can regulate morphological maturation of 
post-migratory premyelinating oligodendrocytes in a unique and opposing fashion 
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that is dependent on the nature of the ECM substrate present and that is, for the 
most part, mediated by FAK’s autophosphorylation and catalytic activity.  Early 
post-migratory premyelinating oligodendrocytes with a reduction in appropriate 
FAK signaling (either via a siRNA knockdown of FAK protein levels or an 
inhibition of FAK catalytic function) in the presence of fibronectin have unbridled 
process networks, whereas when in the presence of laminin-2 oligodendrocytes 
with reduced FAK signaling are unable to form or maintain the appropriately 
substantial morphology required at that stage of development (Figure 4.2 and 
Figure 4.5).  Both signaling pathways in the presence of fibronectin and in the 
presence of laminin-2 converge on FAK and, based on the ECM signal that FAK 
receives, it is able to uniquely modulate the oligodendrocyte process network.   
In the proposed mechanism fibronectin most likely signaling through the 
αvβ3 integrin receptor, would signal for morphological remodeling at early 
developmental time points (Olsen & ffrench-Constant 2005, Lee et al. 2006).  
This association is thought to lead to recruitment of FAK and the SFK member, 
Lyn, to the focal adhesion.  Lyn is the most likely candidate for this association 
since it is upregulated at an early time point during oligodendrocyte development 
and has been shown to be associated with the αvβ3 integrin receptor (Colognato 
et al. 2004, Kramer et al. 1999).   
The restriction of the oligodendrocyte process network in the presence of 
fibronectin could be associated with FAK signaling to cytoskeletal regulators. 
This signaling pathway could involve signaling to Rho family GTPases such as 
RhoA, Rac, and Cdc24, which have been well characterized to modulate the 
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cytoskeleton in various cell types and specifically during oligodendrocyte 
development, as discussed in chapter one (Sypecka et al. 2009, Mitra et al. 
2005, Romer et al. 2006, Hoshina et al. 2007, Rico et al. 2004, Moeller et al. 
2006, Wang et al. 2009).  FAK associates with both GEFs, which promote 
activation of GTPases, and GAPs, which decrease the activity of GTPases, 
allowing for tightly regulated mediation of process morphology (Tomar & 
Schlaepfer 2009).  A limited activation of p190RhoGAP and/or GRAF by FAK 
would enhance RhoA activity, previously demonstrated to mediate cytoskeleton 
contraction and process retraction, which could lead to reduced process network 
formation in the early oligodendrocytes (Liang et al. 2004, Taylor et al. 1998).  
The decrease in FAK association with p130Cas could also lead to restricted Rac 
activation which would reduce process outgrowth limiting the ability of an early 
oligodendrocyte to efficiently differentiate morphologically (Mitra et al. 2005, 
Liang et al. 2004, Schlomann et al. 2009).   
Inappropriate membrane transport, which is observed in oligodendrocytes 
in the presence of fibronectin, could keep proteins from being over produced and 
transported, which would reduce process network expansion, thus reducing the 
risk of over utilizing and depleting resources required for later stages of 
morphological maturation and myelination (Siskova et al. 2006).   
The FAK-mediated effect on oligodendrocyte morphology in the presence 
of fibronectin was also found to be, at least in part, developmentally regulated.  
Later stage post-migratory premyelinating oligodendrocytes no longer respond to 
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the FAK-mediated restriction of the process network in the presence of 
fibronectin (Figure 4.3 and Figure 4.5).   
Interestingly fibronectin levels are upregulated and incongruous fibronectin 
deposits are found throughout MS lesions (Comabella & Martin 2007, Sobel 
1998).  The remodeling of fibronectin as well as other ECM molecules is also 
skewed in MS lesions (Cossins et al. 1997, Sobel 1998).  In concert with the 
above proposed mechanism of early oligodendrocyte morphological remodeling, 
the fibronectin deposits within the MS lesion could prevent efficient maturation of 
differentiating oligodendrocytes and thus restrict remyelination.   
The association of oligodendrocytes with laminin-2 is most likely mediated 
through the α6β1 integrin.  As discussed in chapter three, laminin-2 is a well 
characterized regulator of oligodendrocyte morphological remodeling and the 
α6β1 integrin receptor has been implicated in regulating oligodendrocyte 
maturation and myelination (Baron et al. 2005, Colognato et al. 2007, Olsen & 
ffrench-Constant 2005, Chun et al. 2003, Colognato et al. 2002).  This 
association recruits FAK and the SFK member, Fyn, which in turn signals FAK to 
perform various cellular functions.  Fyn has been greatly implicated in the 
morphological differentiation regulated by laminin-2 signaling and is highly 
associated with α6β1 integrin (Colognato et al. 2004, Osterhout et al. 1999, 
Antonyak & Cerione 2009).   
Due to the observation that neither Fyn nor Lyn levels change in our 
system (Figure 4.8c-f) it is unlikely that there is a feedback loop affecting the 
expression of SFKs, or if there is a feedback loop the small percentage of SFK 
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found in association with FAK (only 3-5%) is not substantial enough to show an 
overall change (Cobb et al. 1994).   
A strong candidate for a downstream signaling target of FAK involved in 
the morphological maturation of oligodendrocytes in the presence of laminin-2 is 
anti-apoptotic serine threonine kinase (Akt) via activation of PI3K.  FAK has been 
shown to activate PI3K which could then activate Akt signaling for various cellular 
functions (Chen & Guan 1994, Del Re et al. 2008).   
The requirement of Akt activity for oligodendrocyte survival has been well 
characterized in vitro (Cui et al. 2005, Bibollet-Bahena & Almazan 2009).  More 
importantly, the activation of the PI3K/Akt signaling pathway has also been 
associated with cytoskeletal rearrangement and morphological remodeling (Del 
Re et al. 2008, Endo & Yamashita 2009).  PI3K-induced Akt activation is 
enhanced with the progression of oligodendrocyte differentiation (Tyler et al. 
2009).  Activation of the PI3K/Akt signaling pathway enhances CNS myelination 
while inhibition of this pathway has been shown to reduce the efficiency of 
myelination (Flores et al. 2008, Barros et al. 2009, Fraser et al. 2008, Tohda et 
al. 2006).  Therefore it is possible that upon association of laminin-2 with α6β1 
integrin Fyn enhances FAK-mediated activation of PI3K which could lead to 
increased activation of Akt and oligodendrocyte differentiation and the expanded 
process network observed.   
The data presented in this dissertation reveal the importance of FAK 
signaling during oligodendrocyte morphological maturation and myelination in 
CNS development.  Due to the opposing roles of FAK in the presence of the 
 95
  
different ECM molecules, fibronectin or laminin-2, meaningful direct regulation of 
FAK in pathological conditions may be difficult to achieve.  A potential approach 
to indirectly modulate FAK-mediated oligodendrocyte morphological maturation 
during pathology would be to manipulate the ECM environment or activation of 
FAK-associated molecules, primarily Fyn and Lyn or integrin receptors.  Thus, 
the findings presented here highlight the importance of better understanding the 
molecular mechanisms regulating developmental myelination in order to develop   
novel therapies which would promote remyelination in MS and other 
oligodendrocyte pathologies.   
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Figure 6.1 Theoretical schematic for FAK-mediated signaling pathways 
regulating morphological maturation of post-migratory premyelinating 
oligodendrocytes.  Upon association of fibronectin with the integrin receptor αvβ3 
a complex of FAK and Lyn is activated.  This activation could lead to the 
regulation of the Rho family of GTPases, primarily RhoA, Rac, and Cdc42, 
enhancing oligodendrocyte process retraction and restricting oligodendrocyte 
process extension thus holding the early stage post-migratory premyelinating 
oligodendrocyte in a less mature morphology.  Upon association of laminin-2 with 
the integrin receptor α6β1, however, activation of a FAK-Fyn complex initiates 
activation of the PI3K/Akt pathway leading to enhanced oligodendrocyte 
morphological maturation and myelination.   
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